Medical Anthropology

A gene, a forest, and a hoe

In 1958 an anthropologist named Frank Livingstone published a paper in American Anthropologist arguing that a gene had spread through West Africa because people cut down trees. The gene was the sickle cell allele. Livingstone's claim was that when yam cultivation moved into the West African forest belt, farmers cleared land, and cleared land collects sunlit standing water, and sunlit standing water is exactly what the mosquito Anopheles gambiae needs to breed. Malaria transmission rose. In that new disease environment, carrying one copy of the sickle allele became an advantage, because it protects against severe falciparum malaria; carrying two copies causes sickle cell disease, which was often fatal in childhood. The allele climbed to high frequency and stayed there, held in place by that trade-off.

Sit with the shape of that argument for a moment. An agricultural decision changed an ecology. The ecology changed a parasite's opportunities. The parasite changed which human genotypes survived. Nothing in the story is purely biological and nothing in it is purely cultural, and if you had studied only genes, or only farming, you would have had half a sentence and no explanation.

That is the argument medical anthropology makes about health in general, and this course is fifteen versions of it. Livingstone was building on Anthony Allison's fieldwork in East Africa a few years earlier, which had established the malaria protection itself; the anthropological contribution was to ask where the malaria pressure came from, and to answer with a hoe.

Key idea: Health outcomes are produced jointly by biology, environment, and human practice, and explanations that use only one of the three usually explain very little.

What the field claims

Medical anthropology is the study of health, illness, healing, and the systems people build around them, across cultures and across time. It is a subfield of cultural anthropology by training and temperament, but it borrows from biological anthropology, epidemiology, clinical medicine, history, and political economy without apology.

Its claim is not that medicine is wrong. It is that sickness is never only a biological event. A tuberculosis infection is a bacterium in a lung; it is also a diagnosis that can cost someone a job, a stigma that can end a marriage, a six-month drug regimen that assumes a stable address, and a national statistic that determines whether a donor agency funds a clinic. All of that is part of what tuberculosis is in a human life, and medical anthropologists study the whole of it.

The field has a corollary that beginners often miss and that Module 3 develops at length: biomedicine, the medicine of hospitals and randomized trials, is itself a cultural system. It has rituals, a hierarchy, a specialized language, initiation rites for its practitioners, and assumptions about persons and bodies that are neither universal nor obvious. Saying so is not an insult. It is the same analytical move anthropologists make about any system of knowledge, and it is what lets you see, for example, why a hospital finds it easier to intensify treatment than to stop it.

Why this matters: Medical anthropology treats sickness as biological, experiential, and political at once, and it treats biomedicine as one healing system among several rather than as the neutral background against which the others are measured.

The biocultural frame, worked twice

The biocultural approach is the habit of asking, for any health pattern, what the body is doing and what people are doing, and refusing to answer until you have both. Two more cases will show you the range.

The first is milk. Most adult mammals stop producing lactase, the enzyme that digests milk sugar, after weaning; most adult humans do too. But in some populations a large majority of adults keep producing it, and those populations turn out to be the descendants of dairying peoples: northern Europeans, and separately several East African pastoralist groups. The genetics are the giveaway. The mutations responsible are not the same one spread around; they are at least four different changes near the lactase gene, arising independently in different populations, all doing the same job. Culture, in the form of a decision to keep cattle and drink their milk, created a selective environment, and biology answered it more than once. This is one of the clearest examples of gene-culture coevolution in our species, and it means that a food that is nourishing in Copenhagen and unremarkable among Maasai herders will make a large share of adults in Beijing or Lima uncomfortable. Neither group is defective. They are living in the bodies their ancestors' subsistence built.

The second case is grimmer, and it is the one that made medical anthropology's reputation.

Kuru: what a funeral has to do with a prion

Among the Fore people of the Eastern Highlands of Papua New Guinea, a disease appeared in the first half of the twentieth century that the Fore called kuru, meaning to shake. It began with unsteadiness, progressed to loss of coordination and speech, and killed within about a year. It was always fatal. By the late 1950s it was killing on the order of a thousand people, and it fell overwhelmingly on adult women and on children of both sexes. Adult men were largely spared.

That distribution is the clue, and it defeated the first explanations offered. A genetic disease should not sort itself so neatly by sex and age. An infectious disease of the ordinary kind should not either. The Fore themselves attributed kuru to sorcery, and given the pattern of who died, sorcery was not a stupid hypothesis; it accounted for the fact that the illness struck particular households.

The answer came from putting two kinds of evidence together. Carleton Gajdusek, a physician working in the highlands from 1957, described the clinical course and later transmitted the disease to chimpanzees, showing it was infectious by a route nobody understood; he shared a Nobel Prize in 1976 for that work. But it was ethnography that explained the epidemiology. Shirley Lindenbaum and Robert Glasse, doing fieldwork among the Fore in the early 1960s, documented the mortuary practice: when a person died, relatives consumed the body, and the distribution of the body followed kinship and gender rules. Adult women and the children with them ate the brain and the parts most heavily loaded with the infectious agent. Adult men mostly did not.

Once you know that, everything resolves. The transmission route was a funeral. The sex ratio was a rule about who ate what. The disease was later understood as a prion disease, a misfolded protein rather than a virus or bacterium, and when the mortuary practice ceased around 1960 the epidemic ended, though cases with incubation periods of more than fifty years continued to appear into the 2000s.

The point: The biological mechanism of kuru was invisible without a cultural fact, and the cultural fact was uninterpretable without the biology. That is the biocultural frame in one case, and it is the reason ethnographers are now routinely part of outbreak teams.

Where the field came from

Medical anthropology has three ancestors, and its arguments still track them.

The first is the tradition of social medicine. In 1848 the Prussian government sent a young pathologist, Rudolf Virchow, to investigate a typhus epidemic in Upper Silesia. He came back and reported that the medical causes were secondary; the epidemic ran on poverty, bad housing, hunger, and the absence of schooling, and his recommendations were political rather than pharmaceutical. Module 5 is Virchow's argument in modern dress.

The second is ethnographic curiosity about non-Western healing. W. H. R. Rivers, an English physician and anthropologist, published Medicine, Magic and Religion in 1924, arguing that the medical practices of Melanesian societies were not superstition badly done but coherent systems that followed logically from beliefs about how the world causes things. That argument is the ancestor of Module 1's third lesson.

The third is applied public health. After the Second World War, health programs kept failing in ways that had nothing to do with the medicine. Benjamin Paul's 1955 collection Health, Culture and Community assembled case after case in which a technically sound intervention foundered on something the planners had not asked about. Module 6 is that literature, sixty years on.

The name and the institutions came in the 1960s and 1970s. The Society for Medical Anthropology is now one of the largest sections of the American Anthropological Association, and the field is one of the most employed corners of the discipline: its graduates work in schools of public health, hospitals, ministries of health, and outbreak response.

Four approaches, four different questions

Medical anthropologists disagree with each other, productively, and the disagreements sort into four broad approaches. You will meet all four in this course. Read the table as four questions, not four teams.

Approach	Central question	Typical evidence	Where it appears in this course
Biocultural / ecological	How do biology, environment, and practice interact to produce this health pattern?	Genetics, nutrition, disease ecology, demography	This lesson; epidemics
Interpretive / meaning-centered	What does this sickness mean to the person and the community?	Illness narratives, explanatory models, symbols	Lessons 2, 4, 5
Critical medical anthropology	Whose interests does this arrangement serve, and how does power get into bodies?	Political economy, policy history, structural analysis	Lessons 12, 13, 14
Applied / clinical	How do we make this program or this clinic actually work for these people?	Program evaluation, participatory research, clinical collaboration	Lessons 7, 11, 14, 15

A good medical anthropologist switches among them. Asking only what an illness means will not tell you why a drug supply chain collapsed; asking only about political economy will not tell you why a mother refuses a treatment she can afford and reach.

What ethnography adds, and what it cannot do

Epidemiology counts. It is very good at telling you that vaccination coverage in a district is 41 percent, that it was 68 percent two years ago, and that the decline is concentrated in certain villages. What it usually cannot tell you is why, because the reason is rarely on the form.

Ethnography answers a different question: what is actually happening, in this place, as people understand and live it. Its method is long-term participant observation, meaning the researcher is there, for months, doing what people do, asking questions in the local language, and noticing what nobody thought to mention because it is obvious to everyone but the newcomer. That is how you find out that the clinic opens at hours when women are fetching water, that the vaccinator is from a rival lineage, or that a previous program took blood and never explained why.

Now the honest limits, because a course that oversells its method has taught you nothing. Ethnography has no sampling frame; you cannot generalize from one village to a nation, and anthropologists who do are overreaching. It cannot establish that an intervention worked, because it has no counterfactual: to know whether a program reduced mortality you need a comparison group, and that is a trial's job, not an ethnographer's. It is slow. It depends heavily on the skill and the position of one researcher, which makes replication awkward. And its findings are often uncomfortable for the agency paying for them, which is a political limit rather than a methodological one but constrains the work all the same.

The productive stance is division of labor. Counting tells you the shape and size of a problem. Ethnography tells you what the problem is made of. Trials tell you whether a fix works. A course that pretends one of the three can do the others' jobs is selling something.

Worth holding on to: Ethnography explains mechanisms and meanings that surveys cannot reach, and it cannot by itself establish prevalence or causal effect. Use it for what it is good at.

Common misconceptions

• Medical anthropology studies exotic healers rather than real medicine. Roughly as much of the field studies hospitals, drug regulators, clinical trials, and insurance systems as studies traditional healing, and Module 3 of this course is entirely about biomedicine.
• Calling biomedicine a cultural system means denying that it works. It means noticing that it makes assumptions, has customs, and could have been organized otherwise. Antibiotics work. So do the hierarchies on a ward, in a different sense.
• Biocultural just means culture affects health. It means the causal arrows run both ways over time: practice reshapes selection pressure, and biology constrains what practices are sustainable.
• The Fore ate people out of superstition. Mortuary consumption among the Fore was a way of honoring and incorporating the dead, governed by explicit kinship rules, and it ended when its consequences became clear. Reading it as savagery gets both the ethics and the epidemiology wrong.
• If ethnographers cannot generalize, their findings do not matter. Mechanisms generalize even when samples do not. Knowing why a program failed in one district tells you what to check in the next fifty.

What to carry forward

• Medical anthropology studies health, illness, healing, and health systems across cultures, treating sickness as biological, experiential, and political at once.
• The biocultural frame insists on both bodies and practices: sickle cell and yam farming, lactase persistence and dairying, kuru and a funeral.
• Kuru was solved when ethnography of Fore mortuary practice explained an epidemiological pattern that biology alone could not.
• The field descends from social medicine, ethnographic study of healing, and applied public health, and its four approaches ask biocultural, interpretive, critical, and applied questions.
• Ethnography reveals mechanism and meaning; it cannot establish prevalence or causal effect, and it should be paired with counting and with trials.

Sources

1. Livingstone, F. B. (1958). Anthropological implications of sickle cell gene distribution in West Africa. American Anthropologist, 60(3), 533-562.
2. National Heart, Lung, and Blood Institute. (n.d.). Sickle cell disease. National Institutes of Health. nhlbi.nih.gov
3. Britannica. (n.d.). Kuru. Encyclopaedia Britannica. britannica.com
4. Lindenbaum, S. (1979). Kuru sorcery: Disease and danger in the New Guinea highlands. Mayfield Publishing.
5. OpenStax. (2024). Introduction to anthropology. Rice University. openstax.org

Two accounts of one child

Lia Lee was born in Merced, California, in 1982, the daughter of Hmong refugees from Laos. She had her first seizure at three months old. Her doctors at the county hospital diagnosed severe epilepsy and prescribed a shifting regimen of anticonvulsants that eventually ran to several drugs at once. Her parents, Foua Yang and Nao Kao Lee, understood what was happening differently: their daughter had qaug dab peg, which translates roughly as the spirit catches you and you fall down. In Hmong understanding this was serious, potentially fatal, and also a mark of distinction, the kind of condition that could indicate a child destined to become a shaman.

Both accounts were about the same body. Both parties wanted the child to live. The doctors thought the parents were dangerously noncompliant; the parents thought the doctors were harming their daughter with drugs that made her dull and sick. In November 1986 Lia had a catastrophic seizure, and she lived in a vegetative state until her death in 2012 at the age of thirty. Anne Fadiman's account of the case, published in 1997, became the most widely assigned book in American medical education for a reason: nobody in it is a villain, and the outcome was still catastrophic.

This lesson gives you the vocabulary the case demands. It is the single most useful set of distinctions in medical anthropology, and it takes about twenty minutes to learn and years to stop misusing.

Three words that are not synonyms

English uses disease, illness, and sickness interchangeably. Medical anthropology does not, and the distinction, sharpened by Arthur Kleinman and by Allan Young in the late 1970s and early 1980s, does real analytical work.

Disease is the practitioner's object: an abnormality in the structure or function of organs and systems, as defined by a professional theory of the body. Epilepsy is a disease. So is a fasting glucose of 9.2 millimoles per litre. Disease is what a diagnostic test measures and what a clinician treats.

Illness is the lived experience: what it feels like to have the problem, what the person believes it is, what it stops them doing, what it means for their marriage and their work and their sense of themselves. Illness is what the patient brings to the appointment. It includes symptoms, but also fear, shame, hope, and a theory of cause.

Sickness is the socialized category: the condition as a public, collective thing, recognized by a society and its institutions. Sickness is what qualifies a person for time off, disability payments, sympathy, or quarantine. It is what an employer, a court, an insurer, or a village recognizes.

The three come apart constantly, and every place they come apart is a research question.

Situation	Disease	Illness	Sickness
Early hypertension found on screening	Present	Absent, the person feels fine	Weak, no social recognition
Chronic fatigue after a viral infection, tests normal	Contested or absent	Severe	Contested, often refused
Grief after a death	Absent by most definitions	Intense	Recognized, with rituals and leave
Lia Lee's seizures	Epilepsy	Qaug dab peg, a spirit event	Recognized by both communities, differently

The core of it: Disease is what the clinician diagnoses, illness is what the person lives, and sickness is what the society recognizes. A patient can have all three, any two, or only one, and most clinical conflict happens in the gaps.

Why the gaps matter more than the overlaps

Consider the first row of that table. A man with a blood pressure of 165 over 100 has a disease and no illness. He feels well. Now his doctor gives him a daily pill that may cause fatigue or affect his sexual function, and a diagnosis that raises his life insurance premium. From the disease standpoint, treatment is obviously correct: the numbers predict strokes. From the illness standpoint, the treatment created the suffering. Medication adherence in asymptomatic hypertension is poor everywhere it has been measured, and this is why. It is not ignorance. It is a rational response to a trade that looks, from inside the life, like paying now for a benefit you can never observe.

Now the second row. In conditions where the disease category is unsettled, myalgic encephalomyelitis and chronic fatigue syndrome, fibromyalgia, and more recently post COVID-19 condition, patients report that the hardest part is not the symptoms but the fight to be recognized as sick at all. The World Health Organization's recognition of post COVID-19 condition mattered enormously to patients precisely because it moved something from illness into sickness: a name, a code, a claim on institutions. Nothing about anyone's body changed on the day of that recognition. Everything about their standing did.

That is the general lesson. Sickness is a status, statuses are allocated, and allocation is political.

The sick role, and where it breaks

The sociologist Talcott Parsons gave the classic account of sickness as a social role in 1951. In his formulation the sick person is temporarily excused from normal duties and is not blamed for the condition, but incurs two obligations in return: to want to get well, and to seek and cooperate with competent help.

It is a useful model and it fails in instructive ways. It assumes illness is temporary, so it fits influenza and not diabetes. It assumes blamelessness, which societies withhold selectively: lung cancer in a smoker, HIV, obesity, and addiction all attract the suspicion that the person did this to themselves, and the sick role is granted grudgingly or not at all. It assumes competent help exists and is reachable. And it assumes the person wants to recover, which is complicated when recovery means losing a disability payment that is the household's only income.

Notice that each failure of the model points at something worth studying. That is what a good model does, even when it is wrong.

Explanatory models: the eight questions

Kleinman, working as a psychiatrist and anthropologist in Taiwan in the 1970s, proposed that everyone involved in an episode of sickness carries an explanatory model, or EM: a set of ideas about what the problem is, what caused it, why it started when it did, what it will do, and what should be done about it. Patients have them. Families have them. So do doctors, and the doctor's EM is not the truth against which the others are measured; it is a model too, generally better supported and still a model.

In a 1978 paper with Leon Eisenberg and Byron Good, Kleinman published the questions that elicit a patient's EM. They are worth memorizing, and they are still taught in medical schools.

1. What do you call your problem? What name does it have?
2. What do you think caused it?
3. Why do you think it started when it did?
4. What does your sickness do to you? How does it work?
5. How severe is it? Will it have a long or a short course?
6. What do you fear most about your sickness?
7. What are the chief problems your sickness has caused you?
8. What kind of treatment do you think you should receive? What results do you hope for?

Read them again and notice how few of them a normal appointment asks. Question 6, about fear, is the one clinicians most often report changing their practice, because the answer is frequently not what they assumed. A patient anxious about a cough may fear tuberculosis and the loss of a job it would bring; another with identical symptoms may fear the cancer that killed their mother. Same disease, entirely different consultations.

Remember: The eight questions are not a cultural sensitivity ritual for patients who seem foreign. They work on everyone, including people who share your language and your assumptions, and especially on the patient you think you already understand.

Illness narratives and the shapes people give suffering

Kleinman's later work turned to illness narratives: the stories people tell to make sense of what is happening to them. The stories are not decoration. They organize what the person notices, what they report, and what they will accept as a cure. A person whose narrative is one of punishment for a moral failure will treat a course of antibiotics differently from one whose narrative is bad luck plus bad water.

Byron Good's fieldwork in Iran in the 1970s produced a fine example. In the town of Maragheh, people spoke of narahatiye qalb, heart distress, describing sensations of the heart fluttering or being pressed. Trace what the phrase connects to and you find a whole semantic network: worry about money, contraceptive use, women's grief, family conflict, the pollution of blood. Heart distress was not a bad translation of anxiety or of cardiac disease. It was a category that bundled a set of concerns in a way that made local sense and had no single English equivalent. Good's term for this is a semantic illness network, and the practical point is that you cannot understand a complaint by translating its head word.

Where this actually helps, and where the evidence is thin

Time for the caveat that separates teaching from advocacy. The disease and illness distinction is analytically excellent, and the eight questions are cheap and often revealing. But the claim that eliciting explanatory models improves clinical outcomes is weaker than enthusiasts imply. Trials of cultural competence and communication training show reasonably consistent improvements in patient satisfaction and in some measures of clinician behavior, and much more mixed results for the outcomes that matter most, such as blood pressure control or hospital readmission. The honest summary is that this is a framework for understanding, with plausible but incompletely demonstrated clinical benefits.

There is also a failure mode worth naming. Used badly, explanatory models turn into a checklist of ethnic beliefs: this group thinks that, so ask about this. Fadiman's book has been read that way, which is close to the opposite of its argument. Individuals within any group vary enormously, most people hold several incompatible models at once, and asking a person what they think beats consulting a card about their culture every time.

In short: Ask the patient, not the culture. The eight questions are a way of finding out what one person believes, not of predicting it from a category.

Common misconceptions

• Illness is just the subjective version of disease. Illness has content the disease category cannot hold: meaning, fear, social consequence, and a theory of cause. It is not a fuzzier version of the same thing.
• The doctor has knowledge and the patient has beliefs. Both have explanatory models. One is usually better supported by evidence, which is a claim about warrant, not about the categories.
• Non-compliance means the patient did not understand. Most studied cases of non-adherence involve patients who understood perfectly and weighed the trade differently, or who could not afford or reach the treatment.
• Explanatory models matter mainly for immigrant or minority patients. They matter for everyone. Middle-class patients in wealthy countries hold elaborate lay theories about inflammation, gut health, stress, and toxins, which shape adherence just as strongly.
• If a society recognizes a sickness, the disease must be real. Sickness is a social status. It can be granted where no disease is found and withheld where one is, and both mismatches have consequences for the person.

Putting it together

• Disease is the clinician's object, illness is the person's experience and interpretation, and sickness is the socially recognized status; the gaps between them generate most clinical conflict.
• Parsons' sick role explains temporary, blameless illness and breaks down for chronic, stigmatized, or contested conditions, and each break marks something worth studying.
• Kleinman's eight questions elicit an explanatory model from anyone, and the question about fear is the one clinicians most often find changes the consultation.
• Illness narratives and semantic networks such as Iranian heart distress show that a complaint bundles concerns that no single-word translation captures.
• Evidence that eliciting explanatory models improves hard clinical outcomes is mixed; the framework's clearest value is in understanding rather than in demonstrated effect.

Sources

1. Kleinman, A., Eisenberg, L., & Good, B. (1978). Culture, illness, and care: Clinical lessons from anthropologic and cross-cultural research. Annals of Internal Medicine, 88(2), 251-258.
2. Fadiman, A. (1997). The spirit catches you and you fall down: A Hmong child, her American doctors, and the collision of two cultures. Farrar, Straus and Giroux.
3. Kleinman, A. (1988). The illness narratives: Suffering, healing, and the human condition. Basic Books.
4. World Health Organization. (n.d.). Coronavirus disease (COVID-19). who.int
5. Brown, N., McIlwraith, T., & Tubelle de Gonzalez, L. (Eds.). (2020). Perspectives: An open invitation to cultural anthropology (2nd ed.). American Anthropological Association. perspectives.americananthro.org
6. OpenStax. (2024). Introduction to anthropology. Rice University. openstax.org

A fourth-century recipe and a Nobel Prize

In 1969 a researcher named Tu Youyou, then thirty-nine and working at the Academy of Traditional Chinese Medicine in Beijing, was assigned to a secret military project to find a treatment for chloroquine-resistant malaria that was killing soldiers in Vietnam. Her team screened thousands of preparations from classical Chinese texts. One plant, Artemisia annua, or qinghao, kept appearing and kept failing in the laboratory.

The breakthrough came from reading the text more carefully. A handbook of emergency prescriptions compiled by Ge Hong around the year 340 instructed the reader to soak a handful of qinghao in water and wring out the juice. Not to boil it. Tu inferred that heat was destroying the active compound and switched to a low-temperature ether extraction. In late 1971 the resulting sample showed complete inhibition of malaria parasites in mice. The compound is artemisinin, artemisinin-based combination therapies are now the frontline treatment for falciparum malaria worldwide, and Tu shared the 2015 Nobel Prize in Physiology or Medicine for the work.

Hold two things in mind at once about that story, because most people can only manage one. The traditional text contained real, specific, transferable knowledge, and it took controlled laboratory testing to extract a usable drug from it. Neither half of the sentence is optional. This lesson is about taking healing systems seriously enough to be genuinely curious about them and rigorous about them at the same time.

What ethnomedicine means

Ethnomedicine is the study of the health beliefs, practices, and healers of a cultural group: how people explain sickness, what they do about it, and who they go to. The word once meant the medicine of other people, the exotic stuff. That usage is dead. In current use, biomedicine is one ethnomedical system among many, with its own history, cosmology, specialists, and initiation rites, and Module 3 studies it in exactly those terms.

Every ethnomedical system answers three questions, and comparing systems means comparing their answers.

• Etiology: what causes sickness?
• Nosology: what kinds of sickness are there, and how are they told apart?
• Therapeutics: what should be done, by whom, and how do you know it worked?

Two ways to explain a sickness

George Foster proposed a distinction in 1976 that has held up. Systems of disease causation tend toward one of two logics.

A personalistic system explains sickness as the result of an agent acting purposefully: a sorcerer, a witch, an offended ancestor, a spirit, a god, or an enemy. The relevant question is not what happened in the body but who did this and why. Diagnosis therefore involves divination, and treatment involves negotiation, confession, restitution, or counter-sorcery. The classic ethnography is Evans-Pritchard's account of witchcraft among the Azande of central Africa in the 1920s, where witchcraft answered a question biomedicine does not attempt: not why does a granary collapse, which everyone knew involved termites, but why did it collapse on this person on this day.

A naturalistic system explains sickness as a loss of equilibrium among impersonal forces: humors, elements, heat and cold, energies, or the balance of the whole organism with its environment. Nobody is to blame. Treatment restores balance through diet, purgation, herbs, heat, cold, or regimen. The Hippocratic and Galenic humors, Ayurveda, and classical Chinese medicine are all naturalistic in this sense, and so, structurally, is a great deal of biomedicine.

Most real systems mix the two. A person may accept that a mosquito transmits malaria and still ask why the mosquito chose them, and both questions can be answered on the same afternoon by different specialists.

Key idea: Personalistic systems ask who caused this sickness and why; naturalistic systems ask what balance has been disturbed. The two answer different questions and coexist easily.

Four systems, compared

Comparison is the point of this table. Read down the columns to see the internal logic of each system, and across the rows to see that each is answering the same set of questions in its own terms.

	Galenic humoralism	Ayurveda	Classical Chinese medicine	Biomedicine
Basic entities	Four humors: blood, phlegm, yellow bile, black bile	Three doshas: vata, pitta, kapha	Qi, yin and yang, the five phases	Cells, organs, molecules, pathogens
Cause of sickness	Humoral imbalance from diet, climate, regimen	Dosha imbalance from diet, season, conduct	Blocked or depleted qi, yin and yang disharmony	Lesion, infection, deficiency, genetic or environmental insult
Diagnosis	History, pulse, urine, temperament	Pulse, tongue, history, constitution	Pulse, tongue, observation, questioning	History, examination, imaging, laboratory tests
Treatment logic	Restore balance by opposites, purge excess	Diet, herbs, oils, purification, regimen	Acupuncture, herbs, moxibustion, dietetics	Remove or counter the cause, replace what is missing
Who heals	Trained physician	Vaidya, trained through lineage or college	Practitioner trained in classical texts or a university	Licensed clinician, trained and credentialed by the state

Notice the shape of the last column. Biomedicine has entities, an etiology, a diagnostic method, a therapeutic logic, and a credentialed specialist, just as the others do. What distinguishes it is not that it has no cosmology but that its claims are tested in a particular way and revised when the tests fail. That is a real and important difference, and it is a difference of method, not of kind.

The hot and cold classification found across Latin America, South Asia, and the Mediterranean is a humoral survival worth knowing about because it shows up in clinics constantly. In many communities foods, illnesses, medicines, and bodily states are classified as hot or cold, with the rule that you treat one with its opposite. A postpartum woman, considered to be in a cold state, may avoid cold foods and cold water; a patient given a medicine classified as hot for a hot illness may quietly stop taking it. None of that will appear in a chart, and all of it affects adherence.

Medical pluralism and the hierarchy of resort

Here is the fact that undermines most simple accounts of traditional versus modern medicine: almost nobody uses one system. Medical pluralism, a term associated with Charles Leslie's work on Asian medical systems in the 1970s, describes the normal situation in which several healing traditions operate in the same society and the same person moves among them.

The movement is not random. Lola Romanucci-Ross, working in the Admiralty Islands of Melanesia, described a hierarchy of resort: a typical sequence people follow, starting with home remedies, moving to a local specialist, and escalating to distant or expensive options as the problem persists. The sequence varies by society, by condition, and by cost. In some places the clinic comes first for an infant's fever and the diviner comes later if the fever does not break; in others the order reverses; for a condition understood as caused by sorcery, the clinic may never be considered relevant at all.

Two consequences follow, and both matter in practice. First, the patient in front of a clinician has usually already tried something, and often is still taking it. Second, patients frequently do not mention this, because they expect to be scolded. Herb and drug interactions are a real clinical problem produced partly by that silence, and the fix is a non-judgmental question, asked as a matter of routine.

What matters here: The normal pattern worldwide is plural use, in a sequence shaped by cost, distance, severity, and the understood cause. Assume your patient has a hierarchy of resort, and ask where you fall in it.

Healers, and what training looks like

Healing specialists are as varied as the systems they work in: herbalists, bonesetters, traditional birth attendants, injectionists, diviners, spirit mediums, and shamans. Two things are worth correcting about the popular image.

The first is that specialization is normal. Many societies have several kinds of healer with distinct competencies, and people sort their problems among them much as a patient chooses between a pharmacist, a physiotherapist, and a surgeon.

The second is that training is usually long and demanding. A shaman's apprenticeship may run for years and involve memorizing large bodies of oral text, learning hundreds of plants, and undergoing ordeals. The word shaman comes from the Tungus languages of Siberia and is used by anthropologists for practitioners who enter altered states of consciousness to act on behalf of a patient, often through a journey narrative. The role carries risk: an unsuccessful healer may be accused of causing harm.

Three kinds of working

When someone asks whether traditional medicine works, the useful reply is to ask what they mean, because there are three answers and they are independent.

Pharmacological efficacy means the substance has a physiological effect that can be isolated and tested. Artemisinin has it. So does willow bark, and reserpine from Rauvolfia serpentina, long used in Ayurveda, which entered mid-century Western practice as an antihypertensive. Many other preparations, tested properly, have none.

Symbolic efficacy is Claude Levi-Strauss's term, from his analysis of a Guna shamanic chant used in Panama for obstructed labor. The chant does not act on the uterus. It provides a narrative in which the woman's pain is given a place, a cause, and a plot with an ending, and Levi-Strauss argued that this reorganization of experience can alter what the body does. Lesson 4 takes that claim apart carefully, because it is both important and easy to overstate.

Social efficacy is the effect on relationships. A healing ceremony that requires a family to gather, air a grievance, and pay compensation can resolve a conflict that was making everyone ill, and the fact that the patient's tuberculosis is unaffected does not make the ceremony pointless. It makes it a different kind of intervention.

Now the other side of the ledger, stated plainly because respect without rigor is its own form of condescension. Some traditional treatments are harmful. A 2008 study in JAMA by Saper and colleagues bought Ayurvedic medicines from United States and Indian internet vendors and found that about one in five contained detectable lead, mercury, or arsenic, some at levels far above regulatory limits. Traditional remedies can also delay effective treatment for conditions where delay is fatal, and the trade in some animal-derived ingredients has driven species toward extinction. A serious anthropology says all of this and still asks why people use these systems, which is a better question than assuming they are fools.

Bottom line: Working can mean pharmacological, symbolic, or social effect. They are different claims, requiring different evidence, and a system can be strong on one and empty on another.

Who owns the knowledge

One more issue, because it will follow you into any global health career. When a pharmaceutical company develops a drug from a plant that a community has used for centuries, who is owed what? The extraction of traditional knowledge without consent or compensation is often called biopiracy, and it has produced decades of legal conflict, including patents on preparations long used in South Asia that were later challenged and revoked. The Nagoya Protocol, adopted in 2010 under the Convention on Biological Diversity and in force since 2014, sets an international framework requiring prior informed consent and benefit sharing for access to genetic resources and associated traditional knowledge. Implementation is uneven and the definitions are contested, but the principle is now established: knowledge held by a community is not simply lying around waiting to be taken.

Common misconceptions

• Ethnomedicine means other people's medicine. Biomedicine is an ethnomedical system too, with a cosmology, a nosology, specialists, and initiation rites.
• Traditional means ancient and unchanging. Healing systems borrow, innovate, and adapt constantly. Contemporary Ayurveda and traditional Chinese medicine are both substantially twentieth-century reconstructions shaped by nationalism and by state standardization.
• People use traditional medicine because they lack access to real medicine. Plural use is common at every income level, including in cities with excellent hospitals, and often runs alongside biomedical treatment rather than instead of it.
• Natural means safe. Dose, contamination, and interaction are the relevant questions, and heavy metals in some preparations are a measured problem, not a rumor.
• If a remedy has no pharmacological effect, nothing is happening. Symbolic and social effects are real effects, and confusing the three kinds of efficacy is the fastest way to argue past someone.

Where this leaves us

• Ethnomedicine studies how any group explains, classifies, and treats sickness, and it includes biomedicine as one system among several.
• Personalistic etiologies name an agent who acted; naturalistic etiologies name a balance that was lost; most societies use both.
• Humoral systems such as Galenic medicine, Ayurveda, and classical Chinese medicine share a structure of entities, imbalance, and restoration by opposites, and hot and cold classifications still shape adherence today.
• Medical pluralism is the norm, and people follow a hierarchy of resort shaped by cost, distance, severity, and understood cause.
• Efficacy comes in pharmacological, symbolic, and social forms, and artemisinin shows that traditional knowledge can be a genuine lead while still requiring controlled testing.

Sources

1. The Nobel Prize. (2015). The Nobel Prize in Physiology or Medicine 2015. Nobel Prize Outreach. nobelprize.org
2. National Center for Complementary and Integrative Health. (n.d.). Health topics A to Z. National Institutes of Health. nccih.nih.gov
3. World Health Organization. (n.d.). Traditional, complementary and integrative medicine. who.int
4. Foster, G. M. (1976). Disease etiologies in non-Western medical systems. American Anthropologist, 78(4), 773-782.
5. Saper, R. B., Phillips, R. S., Sehgal, A., Khouri, N., Davis, R. B., Paquin, J., Thuppil, V., & Kales, S. N. (2008). Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA, 300(8), 915-923.
6. Leslie, C. (Ed.). (1976). Asian medical systems: A comparative study. University of California Press.

Pills labeled placebo

In 2010 a team led by Ted Kaptchuk at Harvard published a trial that should not have worked. Eighty adults with irritable bowel syndrome were randomized either to no treatment or to a bottle of pills whose label said, in plain English, that they contained no active medication. Patients were told outright that the pills were inert, and also told, truthfully, that placebo pills had been shown in studies to produce significant improvement through mind-body self-healing processes. At three weeks, about 59 percent of the open-label placebo group reported adequate relief, against about 35 percent of the controls.

Nobody was deceived. The pills were sugar. And something measurable happened anyway.

That result is the entry point to one of the most misreported topics in medicine. This lesson starts from the popular belief, which is that the placebo effect is a powerful mind-over-matter force capable of curing disease, and traces exactly where that belief goes wrong and what remains standing when it does.

The word is doing two jobs

A placebo is an inert treatment: a sugar pill, a saline injection, a sham procedure. The placebo response is the improvement observed in people who receive one. Those are different things, and most confusion follows from treating them as the same.

Here is the problem in one sentence: the improvement seen in a placebo arm is not caused only by the placebo. At least four other processes are running at the same time.

• Natural history. Most conditions people seek treatment for get better on their own. Colds resolve. Back pain remits. If you enroll someone in a trial and they improve, the default explanation is time.
• Regression to the mean. People enter studies when their symptoms are unusually bad, because that is when they seek help. On any subsequent measurement they will tend to be closer to their average, regardless of what was done to them.
• Reporting bias. Patients who like their clinician and know the study's purpose report improvement. This is politeness and expectation, not physiology.
• Co-interventions. Being in a trial means being examined, monitored, advised, and reminded. Those are treatments.

Asbjorn Hrobjartsson and Peter Gotzsche made this point decisively in 2001. Rather than looking at placebo arms alone, they collected trials that had both a placebo arm and a genuine no-treatment arm, which is the only way to isolate what the placebo itself contributes. Across 114 trials they found little or no effect of placebo on binary outcomes and on objective measurements, and a modest effect on continuous subjective outcomes, most reliably pain. Their later updates reached the same conclusion.

The upshot: A large share of what people call the placebo effect is natural history, regression to the mean, and reporting bias. The genuine placebo response is real, smaller than advertised, and concentrated in subjective symptoms rather than in disease processes.

What is left is genuinely strange

Having deflated the claim, now take the residue seriously, because it is well documented and it does not fit a simple story about people just saying they feel better.

In 1978 Jon Levine, Newton Gordon, and Howard Fields ran a study on patients in pain after dental surgery. Placebo produced analgesia, as expected. Then they administered naloxone, which blocks opioid receptors, and the placebo analgesia disappeared. That is a strong result: it means placebo analgesia is at least partly mediated by the body's own opioid system, and it can be switched off pharmacologically. Later imaging work has mapped the circuitry, and in Parkinson's disease, placebo administration has been shown to release dopamine in the striatum, measured directly rather than reported by patients.

So the honest statement has two halves. Placebo responses do not cure infections, shrink tumors, or repair fractures. They do produce real, measurable changes in pain processing, in some motor symptoms, in nausea, and in other symptom systems, through mechanisms that can be identified and blocked.

The dose is the meaning

This is where anthropology earns its place in the discussion. Daniel Moerman argued that the term placebo effect is a category error, since an inert substance by definition does nothing. What produces the response is the meaning of the treatment to the person receiving it: the ritual, the expectation, the authority of the person handing it over, the story the treatment tells. He proposed calling it the meaning response, and the evidence that meaning is the active ingredient is that it behaves like a dose.

• Moerman's analysis of ulcer treatment trials found that placebo healing rates varied enormously between studies, and that regimens requiring four doses a day produced better placebo healing than regimens requiring two, with the same inert pill.
• Injections generally produce larger placebo responses than pills, and procedures larger responses than injections.
• In a 2008 study by Waber and colleagues, participants told a placebo painkiller cost 2.50 dollars per dose reported more pain relief than those told the identical pill was discounted to ten cents.
• Branding, color, and the confidence of the clinician all shift responses measurably.

Notice what all of these have in common. None of them changes the substance. All of them change what the treatment means.

Why this matters: If meaning is the operative ingredient, then the ritual around a treatment is not a decoration on top of the pharmacology. It is a second intervention running in parallel, and it operates in active treatments too.

Sham surgery, and the uncomfortable trials

The most striking evidence comes from surgery, because surgery has a very large ritual and, until recently, very few placebo-controlled trials.

In 2002 Bruce Moseley and colleagues published a trial in the New England Journal of Medicine in which 180 patients with knee osteoarthritis were randomized to arthroscopic debridement, arthroscopic lavage, or a sham procedure with skin incisions and no instrument entering the joint. At every follow-up point over two years, the sham group did as well as the surgical groups.

In 2018 the ORBITA trial did something similar for stable angina, comparing percutaneous coronary intervention with a sham procedure in which patients were sedated and catheterized but no stent was placed. The stented group did not show a statistically significant advantage on the primary endpoint of exercise time increment, in a procedure performed hundreds of thousands of times a year.

Both trials were fiercely contested on grounds of size, endpoint choice, and patient selection, and both remain contested. What they establish is narrower than the headlines claimed and still important: the experience of receiving a serious intervention accounts for a substantial part of the benefit patients report from some procedures.

The nocebo response, which is the same mechanism running backwards

Expectation cuts both ways. A nocebo response is a harmful effect produced by an inert exposure or by negative expectation, and it is a large practical problem.

The clearest demonstration is the SAMSON trial, published in 2020. Sixty patients who had stopped taking statins because of side effects were given twelve months of bottles in rotation: four months of statin, four of placebo, four of nothing, in randomized order, recording daily symptom scores on a phone. About 90 percent of the symptom burden they reported while taking the statin was also present while taking the placebo. Half of the participants restarted statin therapy afterward.

That result should be handled with care in both directions. It does not show that statin side effects are imaginary; some are real and some patients genuinely cannot tolerate the drugs. It shows that the attribution of symptoms to a drug is powerfully shaped by expectation, and that a patient told to watch for muscle aches will find muscle aches, because most people have some.

So what?: How a clinician describes a side effect changes how often the side effect is reported. That is an ordinary finding about meaning, and it has consequences for informed consent that the field has not fully resolved.

Culture, carefully

Do placebo responses vary across societies? Moerman's comparison of ulcer trials suggested they do, with placebo healing rates varying substantially between countries. It is a suggestive finding and it needs a caveat that is easy to skip: trials in different countries differ in diagnostic criteria, in follow-up procedures, in patient populations, and in how outcomes are measured, so cross-national differences in placebo response may be differences in trials rather than in people.

What is better established is that placebo responses vary with the local plausibility of the treatment. A therapy that fits a person's understanding of their body and their sickness produces more response than one that does not, which is precisely what a meaning-based account predicts, and it is one reason why an intervention that performs well in one setting can perform poorly in another for reasons that have nothing to do with its pharmacology.

The ethics, which are not simple

If placebos help, may a clinician prescribe one? Surveys of physicians in several countries have repeatedly found that substantial fractions report using placebos or, more often, impure placebos: vitamins, antibiotics for viral illness, or subtherapeutic doses given largely for their meaning. Deception undermines informed consent and, if discovered, the trust that makes the meaning response work in the first place.

Open-label placebo, the design in the trial that opened this lesson, is interesting exactly because it sidesteps that problem. The evidence base has grown since 2010, with positive trials in irritable bowel syndrome, chronic low back pain, and cancer-related fatigue, and the effects are modest, measured on subjective endpoints, and studied in small samples. It is a promising line of research, not a treatment protocol, and anyone who tells you otherwise has skipped the sample sizes.

Common misconceptions

• The placebo effect proves the mind can heal the body of anything. Measured placebo responses affect symptom systems such as pain, nausea, and some motor function. They do not clear infections or shrink tumors.
• A third of patients are placebo responders. The one-third figure comes from a 1955 paper whose method could not separate placebo response from natural history. There is no fixed placebo responder rate, and no stable placebo-responder personality has been identified.
• Placebos only work if the patient is deceived. Open-label trials show responses when patients are told the pills are inert, which is hard to explain on a pure deception account.
• If a treatment beats placebo only slightly, the placebo response is doing nothing useful. Both arms get the meaning response; the trial measures what the drug adds on top of it. Patients receive both.
• Nocebo means the patient is imagining side effects. The symptoms are experienced and reported honestly. What expectation changes is which sensations get noticed and what they get attributed to.

The short version

• Improvement in a placebo arm mixes natural history, regression to the mean, reporting bias, and co-interventions with any true placebo response, and only three-arm trials can separate them.
• Hrobjartsson and Gotzsche found little placebo effect on objective and binary outcomes, and a modest one on subjective continuous outcomes, especially pain.
• The residue is real: placebo analgesia is partly opioid-mediated and can be blocked by naloxone, and placebo dopamine release has been measured in Parkinson's disease.
• Moerman's meaning response reframes the phenomenon: dosing schedule, route, price, branding, and clinician manner all shift the response because they change what the treatment means.
• Nocebo responses are the same mechanism in reverse, as SAMSON showed for statin side effects, and open-label placebo is a promising but small and symptom-limited line of research.

Sources

1. Kaptchuk, T. J., Friedlander, E., Kelley, J. M., Sanchez, M. N., Kokkotou, E., Singer, J. P., Kowalczykowski, M., Miller, F. G., Kirsch, I., & Lembo, A. J. (2010). Placebos without deception: A randomized controlled trial in irritable bowel syndrome. PLoS ONE, 5(12), e15591. doi.org
2. Britannica. (n.d.). Placebo. Encyclopaedia Britannica. britannica.com
3. National Center for Complementary and Integrative Health. (n.d.). Research on placebo effects. National Institutes of Health. nccih.nih.gov
4. Hrobjartsson, A., & Gotzsche, P. C. (2001). Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. New England Journal of Medicine, 344(21), 1594-1602.
5. Moerman, D. E. (2002). Meaning, medicine and the placebo effect. Cambridge University Press.
6. Wood, F. A., Howard, J. P., Finegold, J. A., Nowbar, A. N., Thompson, D. M., Arnold, A. D., Rajkumar, C. A., Connolly, S., Cegla, J., Stride, C., Sever, P., Norton, C., Thom, S. A. M., Shun-Shin, M. J., & Francis, D. P. (2020). N-of-1 trial of a statin, placebo, or no treatment to assess side effects. New England Journal of Medicine, 383(22), 2182-2184.

Sixty people, three cities, one symptom

In a study published in 2015, Tanya Luhrmann and colleagues interviewed sixty people diagnosed with schizophrenia who heard voices: twenty in San Mateo, California, twenty in Accra, Ghana, and twenty in Chennai, India. Everyone in the study heard voices. What the voices did was strikingly different.

The American participants overwhelmingly described the voices as an assault. They used the language of intrusion and of violence, and they described them as symptoms of a brain disease, without relationship or personality. Many participants in Chennai described voices of relatives, often giving instructions about domestic tasks, and described ongoing relationships with them. Several participants in Accra described voices as spiritual in origin, some as coming from God, and described them as, on balance, positive.

Note what does not vary and what does. Hearing voices is present in all three sites. The content, the relationship, the interpretation, and the distress vary a great deal. That pattern is the argument of this lesson, and it has to be stated carefully because it is very easy to slide from it into two opposite errors.

Two words that keep the argument honest

Transcultural psychiatry distinguishes two ways culture can act on mental illness.

A pathogenic effect means culture helps cause the disorder: without these social conditions, this disorder would not occur, or would occur far less.

A pathoplastic effect means culture shapes the form: the content of delusions, the idiom in which distress is expressed, how symptoms are interpreted, what the course looks like, and who recovers.

The Luhrmann finding is primarily pathoplastic. Nobody in it is claiming culture causes psychosis. The claim is that what the voices say and mean, and therefore how much they hurt, tracks the social world the hearer lives in.

The two errors that this distinction protects against are worth naming. The first is the view that mental illness is a purely biological universal and culture is decoration; this is contradicted by the data on content, course, and outcome. The second is the view that mental illness is nothing but a cultural construction; this is contradicted by the presence of psychosis, severe depression, and suicidal despair in every society where anyone has looked, and it is a position that tends to be held most confidently by people who have never sat with someone in the middle of an episode.

Key idea: Culture can be pathogenic, helping to cause disorder, or pathoplastic, shaping its form and course. Most cross-cultural findings in psychiatry are about the second, and reading them as the first produces bad arguments in both directions.

The outcome puzzle and how it fell apart

The most cited claim in cultural psychiatry came from the World Health Organization's own studies. The International Pilot Study of Schizophrenia, launched in the late 1960s across nine countries, and its successor the Determinants of Outcome study reported that patients in what were then called developing countries had better outcomes at follow-up than patients in industrialized ones. The finding was extraordinary, and it was explained by tighter kin networks, less stigma, more available work roles, and lower expressed emotion in families.

It became an axiom, repeated in textbooks for thirty years. Then, in 2008, Alex Cohen, Vikram Patel, R. Thara and Oye Gureje published a systematic review with the deliberately unfriendly title Questioning an Axiom. Their conclusion was that the evidence was much weaker than the claim: outcomes varied enormously within the so-called developing world, follow-up rates differed between sites in ways that could produce the result artifactually, definitions of good outcome were inconsistent, and some longer-term follow-ups in low-income settings found high mortality and severe disability.

What should you do with that? Not conclude that the original studies were worthless, and not keep repeating the axiom. The defensible position is that outcomes for psychosis vary considerably across settings, that the reasons are not settled, and that a very widely believed cross-cultural finding turned out to rest on shakier ground than its popularity suggested. That is a normal event in science and it is worth watching happen.

Culture-bound syndromes, and why the category died

For most of the twentieth century, psychiatry kept a special drawer for disorders that appeared in particular societies and did not fit standard categories. The fourth edition of the American Psychiatric Association's diagnostic manual, published in 1994, formalized this with an appendix listing twenty-five culture-bound syndromes. Among them:

Syndrome	Where described	Presentation
Amok	Malaysia, Indonesia, Philippines	A period of brooding followed by a sudden violent outburst, often with amnesia afterward
Ataque de nervios	Caribbean and Latin American communities	Shouting, crying, trembling, and collapse, typically after a family shock
Susto	Latin America	Illness attributed to soul loss after a frightening event, with insomnia, appetite loss, and weakness
Taijin kyofusho	Japan	Intense fear of offending or embarrassing others through one's appearance, odor, or gaze
Shenjing shuairuo	China	Neurasthenia: fatigue, headache, poor concentration, sleep disturbance, and bodily complaints

Now the objection that eventually retired the category. If the appendix lists conditions bound to a culture, what are the conditions in the main text bound to? The main text was not culture-free. It was a product of North American and European psychiatry, and several of its categories look, on inspection, at least as locally shaped as anything in the appendix. Anorexia nervosa in its fat-phobic form is the most discussed example, and Sing Lee's research in Hong Kong is why: before the mid-1990s, the Chinese patients he studied with severe self-starvation typically did not report fear of fatness, giving reasons such as bloating or absent appetite instead. After heavy local media coverage of a young woman's death in 1994 explained anorexia in Western terms, the presentation reported in Hong Kong shifted toward the fat-phobic form. That sequence is what a culture-shaped diagnosis looks like from the inside.

The 2013 fifth edition of the manual dropped the culture-bound category and replaced it with three cultural concepts of distress: cultural syndromes, meaning clusters of symptoms that co-occur in a group; cultural idioms of distress, meaning the local ways people talk about suffering; and cultural explanations, meaning locally recognized causes. It also introduced a Cultural Formulation Interview, a structured set of questions for eliciting a patient's own understanding, which is Kleinman's explanatory model approach arriving in official psychiatry three decades after he proposed it.

The point: The culture-bound category collapsed not because the syndromes were unreal, but because it implied a culture-free main text that does not exist.

The category fallacy, and why depression looks different in Hunan

Kleinman named the underlying error the category fallacy: taking a diagnostic category developed in one society, applying it in another where it has no local coherence, and treating whatever it captures as the same thing.

His own fieldwork supplies the case. In 1980 Kleinman studied a group of patients in Hunan, China, who had been diagnosed with neurasthenia, then an extremely common Chinese diagnosis describing fatigue, headache, dizziness, and poor sleep. Applying American criteria, he found that the large majority met criteria for major depressive disorder. But the patients did not present with sadness, and they did not organize their suffering around mood. They presented with the body.

Read that result the lazy way and it says Chinese patients have depression but call it something else. Read it carefully and it is more interesting. Expressing distress bodily is not a failure to notice one's feelings; it is a different, coherent way of locating suffering, in a setting where a mood complaint carried political and social risk and a bodily complaint carried legitimate access to care. Somatization is the technical term, and the mistake to avoid is treating it as an inferior version of psychological insight.

The global mental health argument

This is a live dispute with serious people on both sides, and you should be able to state each position in its own terms.

The case for global mental health rests on scale and neglect. WHO estimates that more than three quarters of people with mental disorders in low- and middle-income countries receive no treatment at all, and that more than 700,000 people die by suicide each year worldwide. In 2020 WHO and Human Rights Watch documented the shackling of people with mental health conditions in around sixty countries, including chaining in homes, prayer camps, and institutions. The movement's argument is that in the face of that, debating the cultural validity of diagnostic categories is a luxury, and that task-shifting interventions delivered by trained lay workers have shown benefit in randomized trials in Pakistan, India, Uganda, and elsewhere.

The case against is not a defense of shackling. It is that exporting a diagnostic system carries assumptions with it: that suffering is located in individuals rather than situations, that it is treated by specialists and pharmaceuticals, and that local healing resources are obstacles rather than assets. Critics point to post-disaster trauma counseling programs, notably in Sri Lanka after the 2004 tsunami, where large numbers of foreign counselors arrived with a PTSD framework that many local people did not use and did not want, while the material needs people did name went unmet. Derek Summerfield's argument, made repeatedly since the 1990s, is that this is a category fallacy operating at the scale of foreign policy, and that pharmaceutical markets have an obvious interest in the expansion.

Where does the evidence leave you? Roughly here. Task-shifted psychological treatments for common mental disorders have real trial support in several low-income settings, so the strong version of the critique, that none of this works or belongs, is not sustainable. And several large post-disaster mental health efforts have been poorly matched to what people actually reported needing, so the strong version of the movement's claim, that a diagnostic framework travels intact, is not sustainable either. The productive question is not whether but which: which conditions, which interventions, delivered by whom, in whose categories.

Worth holding on to: Both sides of the global mental health argument are pointing at something real. Untreated severe mental illness is a catastrophe; imported diagnostic frameworks can misdescribe suffering and crowd out local resources. Any position that only sees one of those is not worth much.

Common misconceptions

• Culture-bound syndromes are exotic conditions that Western people do not get. The category was retired partly because Western psychiatry's own categories are culturally shaped, and several conditions common in wealthy countries fit the definition well.
• Somatization means a patient is unable to recognize their emotions. Bodily idioms of distress are coherent and often locally advantageous ways of expressing and legitimating suffering.
• Schizophrenia has better outcomes in poor countries. That claim was based on WHO studies whose evidence a 2008 systematic review found much weaker than the axiom implied.
• If a disorder is culturally shaped, it is not real. Shaping is not fabrication. The distress, disability, and mortality are measurable regardless of how the category was assembled.
• Critics of global mental health want people left untreated. The serious critique is about which categories and which interventions travel, not about whether to help.

What you now know

• Culture can act pathogenically, contributing to cause, or pathoplastically, shaping content and course; the Luhrmann voice-hearing study is a clear pathoplastic result.
• The long-standing claim of better schizophrenia outcomes in developing countries was challenged in 2008 on grounds of follow-up, definitions, and within-region variation.
• The culture-bound syndrome appendix was replaced in 2013 by cultural concepts of distress and a Cultural Formulation Interview, because the category implied a culture-free main text.
• Kleinman's category fallacy and his Hunan neurasthenia study show how a diagnostic label can capture something real while misdescribing how people experience and present it.
• Global mental health is defended by the scale of untreated illness and trial evidence for task-shifting, and criticized for exporting individualized categories that can displace local resources.

Sources

1. World Health Organization. (n.d.). Mental health. who.int
2. National Institute of Mental Health. (n.d.). Mental health information. National Institutes of Health. nimh.nih.gov
3. American Psychiatric Association. (n.d.). Diagnostic and Statistical Manual of Mental Disorders. psychiatry.org
4. Luhrmann, T. M., Padmavati, R., Tharoor, H., & Osei, A. (2015). Differences in voice-hearing experiences of people with psychosis in the USA, India and Ghana: Interview-based study. British Journal of Psychiatry, 206(1), 41-44.
5. Cohen, A., Patel, V., Thara, R., & Gureje, O. (2008). Questioning an axiom: Better prognosis for schizophrenia in the developing world? Schizophrenia Bulletin, 34(2), 229-244.
6. Kleinman, A. (1988). Rethinking psychiatry: From cultural category to personal experience. Free Press.

The errors a surgical program will forgive

In the mid-1970s the sociologist Charles Bosk spent eighteen months as an observer on the surgical services of a university hospital, watching residents being trained and, crucially, watching what happened when they made mistakes. He found that the program sorted errors into kinds, and treated them very differently.

Technical errors, where a resident's skill fell short of the task, were expected and forgiven; that is what training is for. Judgmental errors, where a resident chose the wrong strategy, were also largely forgiven, with instruction attached. But normative errors were treated as grave. A normative error was a failure to fulfill the role: not telling an attending about a problem, not being present, letting the team down, dodging the tedious work. A resident who made repeated technical errors was a learner. A resident who made normative errors was, in the eyes of the program, a bad doctor.

Read that finding again, because it tells you something no textbook of surgery contains. What a profession punishes reveals what it actually values, and this profession valued reliability and honesty toward the team above technical excellence. Bosk's title, Forgive and Remember, describes the mechanism: errors are forgiven and also recorded, in the informal memory that decides whose career advances.

That is an anthropological finding about biomedicine, produced by ordinary fieldwork, and it is the model for this lesson. The hospital is a fieldsite. Its practices have logics that are not only clinical.

Learning to see like a clinician

Medical training does something more thorough than transferring information: it rebuilds perception. Byron Good, studying Harvard medical students in the 1980s and 1990s, described how students learn to construct the person in front of them as a case, an object composed of findings, values, and images that can be discussed, presented, and acted upon.

You can watch this happen in the genre of the case presentation. A patient says: I have been so tired since my mother died, and my chest hurts when I climb the stairs, and I am worried because my brother had a heart attack at fifty. The presentation says: fifty-three-year-old male with exertional chest pain, family history of premature coronary artery disease. Everything clinically actionable survives. The mother, the worry, and the word so have gone. The transformation is efficient, it is teachable, and it discards exactly the material Lesson 2 called illness.

Anthropologists call the informal side of this the hidden curriculum: everything students learn from the structure and culture of training rather than from the syllabus. A curriculum may teach empathy in the second year. The hidden curriculum teaches, in the third, that the resident who finishes rounds fastest is admired, that the patient in bed 12 is called the gallbladder, and that expressing distress about a death marks you as not yet toughened. Studies of medical students consistently find that measured empathy declines during clinical training, and while the size and interpretation of that decline are debated, the direction is not what any formal syllabus intended.

Remember: Training reorganizes perception, not just knowledge. The hidden curriculum teaches the values that survive contact with the ward, and it usually beats the stated one.

Ritual, and why the word is not an insult

Anthropologists use ritual to mean formalized, repeated, symbolically dense action; the word carries no implication that the action is useless. Hospitals are full of ritual in this sense, and some of it is also technically necessary, which is exactly what makes it interesting.

The surgical scrub is the cleanest example. A portion of it is microbiologically justified; the specified duration, the sequence of hands and forearms, the prohibition on touching anything afterward, and the assisted gowning also mark a boundary between two zones and two states of the person. Watch who is allowed to break the sterile field and how the violation is treated, and you are watching a purity rule being enforced.

Morning rounds are a ritual of hierarchy: a procession whose order, speaking rights, and physical arrangement encode rank precisely. The morbidity and mortality conference is a ritual of accountability, in which a bad outcome is publicly narrated in a formally structured way that both examines and contains blame. Admission is a ritual of transition, in the classical sense: the person is separated from ordinary life, stripped of clothes and given a gown, assigned a number, and placed under new rules about eating, sleeping, and moving. Erving Goffman's analysis of institutional life describes the mechanism, and any patient who has waited on a trolley in a gown recognizes it immediately.

Two hierarchies, and the game between them

A hospital contains at least two parallel status systems, and much of what happens there is negotiation between them.

The medical hierarchy runs from attending physician through fellow, resident, and intern to medical student, and it is explicit, public, and tied to authority over decisions. The nursing hierarchy has its own ladder and its own claims to knowledge, in particular continuous presence at the bedside, which physicians do not have.

Leonard Stein's 1967 paper described the resulting negotiation as the doctor-nurse game, in which a nurse who has a clear recommendation must make it appear to be the physician's own idea, and the physician must request advice without appearing to need it. Both parties knew the rules and neither could acknowledge them. The game has weakened since, with nursing professionalization, protocol-driven care, and formal escalation policies, and elements of it survive wherever authority and knowledge sit in different people.

Renee Anspach's study of neonatal intensive care units showed why this matters clinically. Physicians, she found, based prognoses mainly on technological cues: laboratory values, imaging, monitor traces. Nurses, at the bedside continuously, relied more on interactive cues, meaning how the infant responded to being handled, spoken to, and fed. Neither is irrational. They are different evidence bases, produced by different positions in the institution, and disagreements about a baby's prognosis often turn out to be disagreements about which cues count.

What matters here: Where a person stands in an institution determines what evidence they see. Conflicts that look like differences of opinion are often differences of vantage point.

What the money is teaching

Institutions have incentives, and incentives shape behavior more reliably than values statements do. Two examples.

In 1983 the United States Medicare program moved hospital payment onto diagnosis-related groups, paying a fixed amount per admission based on diagnosis rather than reimbursing costs incurred. Hospital behavior changed rapidly: lengths of stay fell, discharge planning became a profession, and clinicians developed a new vocabulary for patients who were medically stable but socially unready to leave. The clinical literature of the period argued about whether patients were going home quicker and sicker. Whatever the verdict, the point stands: a payment rule rewrote bedside practice.

The second example is the electronic health record. A widely cited 2016 time and motion study by Christine Sinsky and colleagues followed physicians in four specialties and found they spent about 49 percent of their office day on the record and desk work, against about 27 percent on direct face time with patients, with further record work in the evening. The record was introduced to improve safety and coordination, and it also became a billing and legal document, which is why it demands what it demands. Watch where a clinician's eyes go during your next appointment. That is an institution's requirements, made visible in a body.

Medicalization, and its reverse

The concept that ties this module together is medicalization: the process by which a human problem comes to be defined and treated as a medical one. Peter Conrad's work traces the pattern across childbirth, alcoholism, hyperactivity, menopause, shyness, obesity, and aging itself.

Medicalization is not automatically bad, and this is where students most often go wrong. Defining alcohol dependence as a disorder rather than a moral failure made treatment possible and reduced punishment. Defining a difficult child's behavior as a treatable condition can bring a family real relief. What medicalization does is relocate a problem: it moves authority to clinicians, moves the cause into the individual body, and moves the response toward diagnosis and treatment and away from changing the situation. Sometimes that is the right move. Sometimes it converts an intolerable school, workplace, or housing situation into a prescription.

Demedicalization also happens, and it demonstrates that these boundaries are decided rather than discovered. Homosexuality was listed as a mental disorder in American psychiatry's manual until the board voted to remove it in December 1973, a decision confirmed by a membership referendum the following year, under sustained pressure from activists and from research that failed to find the pathology the diagnosis assumed. Childbirth has been partly demedicalized in some countries through midwifery-led care. Both directions are worth studying, and neither happens by discovery alone.

In short: Medicalization relocates authority and cause. Ask in each case what it makes visible, what it makes invisible, and who gains the right to decide.

Common misconceptions

• Studying hospitals anthropologically means criticizing medicine. Bosk's account of error and Anspach's account of prognosis are descriptions of how expert work actually happens, and both have been used inside medicine to improve it.
• Calling a hospital practice ritual means it is medically pointless. Ritual means formalized, repeated, symbolically dense action. The surgical scrub is ritual and also microbiology.
• Medicalization is always harmful. It has removed blame and enabled treatment in many cases. Its cost is that it individualizes problems that may not be individual.
• The hidden curriculum is a failure of a few bad programs. It is a structural feature of apprenticeship in any high-pressure institution, which is why it must be managed rather than simply deplored.
• Nurses and doctors disagree about prognosis because one group is better informed. They often occupy different observational positions and therefore see different evidence.

Pulling it together

• Bosk found that surgical training forgave technical and judgmental errors while treating normative errors as disqualifying, which reveals what the profession actually values.
• Clinical training rebuilds perception, teaching students to construct patients as cases; the case presentation systematically removes the illness material a patient brings.
• Hospital rituals of purity, hierarchy, accountability, and transition organize behavior alongside their technical functions.
• Parallel medical and nursing hierarchies produce negotiation, and different institutional positions produce different evidence, as in Anspach's technological and interactive cues.
• Payment rules and record systems reshape bedside practice, and medicalization and demedicalization move problems in and out of medical authority by decision rather than discovery.

Sources

1. Bosk, C. L. (2003). Forgive and remember: Managing medical failure (2nd ed.). University of Chicago Press. (Original work published 1979)
2. Conrad, P. (2007). The medicalization of society: On the transformation of human conditions into treatable disorders. Johns Hopkins University Press.
3. Sinsky, C., Colligan, L., Li, L., Prgomet, M., Reynolds, S., Goeders, L., Westbrook, J., Tutty, M., & Blike, G. (2016). Allocation of physician time in ambulatory practice: A time and motion study in 4 specialties. Annals of Internal Medicine, 165(11), 753-760.
4. Agency for Healthcare Research and Quality. (n.d.). Patient safety. U.S. Department of Health and Human Services. ahrq.gov
5. Centers for Medicare & Medicaid Services. (n.d.). Acute inpatient prospective payment system. cms.gov
6. OpenStax. (2024). Introduction to anthropology. Rice University. openstax.org

Eighteen seconds

In 1984 Howard Beckman and Richard Frankel published a study in which they audiotaped seventy-four primary care visits and simply timed things. In most of those visits the physician interrupted the patient's opening statement of concerns. The average time before the interruption was eighteen seconds, and in only about a quarter of the visits did the patient get to finish saying what they had come about.

The finding was widely quoted, taught, and used to justify communication training. Fifteen years later, Marvel and colleagues repeated the measurement across 264 encounters and found that patients completed their opening statement in about 28 percent of visits, with a mean of 23.1 seconds before redirection. In 2019, Singh Ospina and colleagues did it again, in a study of 112 encounters, and found clinicians elicited the patient's agenda at all in about 36 percent of visits, with a median of eleven seconds before interruption when they did.

Thirty-five years, three studies, essentially no improvement. That is the problem this lesson is about, and it is not a problem of individual rudeness. It is a structural feature of an encounter with more to do than time to do it in, and understanding it that way is the only route to changing it.

What kind of event a consultation is

Treat the consultation as an ethnographer would: a bounded interaction with a recognizable structure, its own rules about who speaks, and a great deal of asymmetry.

The asymmetries stack. One party has technical knowledge and the other has the body under discussion. One is dressed and the other may not be. One controls the length of the encounter, the record, and the prescription. One does this thirty times a day and the other has been waiting three weeks and rehearsing. When a patient seems to say the wrong things in the wrong order, remember that they are a novice in a genre their counterpart performs professionally.

The genre has a standard shape: opening, agenda-setting, history, examination, explanation and planning, closing. Two moments in it are studied heavily because they go wrong so reliably.

The first is agenda-setting. Patients typically have more than one concern, and the order in which they mention them does not reflect importance; the most worrying item is often held back. If the clinician acts on the first item mentioned, the encounter can be spent on the wrong problem. The tested fix is cheap: after the first concern, ask what else, and keep asking until the answer is nothing, before starting to work on anything.

The second is the closing. The doorknob complaint, raised as the patient stands to leave, is well known in the literature and it is a rational response to the structure: the patient has spent the visit deciding whether this doctor can be told the frightening thing. Good agenda-setting at the start is the main defense against it.

The point: The order in which concerns are mentioned is not the order of importance. Eliciting the full agenda before working on any item is the single best-supported change to the shape of a consultation.

When there are three people and two languages

Interpretation deserves its own section, because the errors are measurable and the stakes are high.

Glenn Flores and colleagues audiotaped pediatric encounters involving Spanish-speaking families and counted interpretation errors: 396 of them across thirteen encounters, of which about 63 percent had potential clinical consequences. The errors were of identifiable types: omission, addition, substitution, editorializing, and false fluency. Crucially, errors made by ad hoc interpreters, meaning family members, bilingual staff pulled from other jobs, and in some cases children, were considerably more likely to be clinically consequential than those made by trained hospital interpreters.

The legal position in the United States follows from Title VI of the Civil Rights Act of 1964, which requires recipients of federal funding to provide meaningful access to people with limited English proficiency, reinforced by Executive Order 13166 in 2000 and by the national standards for culturally and linguistically appropriate services published by the Department of Health and Human Services. In practice the barrier is rarely the law; it is the extra twenty minutes an interpreted visit takes on a schedule built for fifteen.

Working with an interpreter has a practical grammar worth learning: speak to the patient, not the interpreter; use short segments; avoid idiom, which does not survive translation; expect the interpreter to say when something has no equivalent; and never use a child. Note also that an interpreter is not a neutral conduit. They are a third party who may share a community with the patient, which affects what is said about stigmatized matters, and who may soften a message to be kind. That is a human being doing a hard job, not a fault to be engineered away.

Bias is in the room, and sometimes in the device

A 2016 study by Kelly Hoffman and colleagues, published in the Proceedings of the National Academy of Sciences, asked white medical students and residents about beliefs concerning biological differences between Black and white people, including plainly false ones such as differences in skin thickness or nerve endings. About half endorsed at least one false belief. Those who did rated Black patients' pain as lower and made less accurate treatment recommendations for them.

That is a study about people. Here is one about equipment. In 2020 Michael Sjoding and colleagues reported in the New England Journal of Medicine that pulse oximeters, which estimate blood oxygen through the skin, missed hypoxemia about three times as often in Black patients as in white patients when checked against direct arterial measurement. The device is calibrated on light passing through tissue, and the calibration performs unevenly across skin pigmentation. During the COVID-19 pandemic, when oxygen saturation determined who received treatment and admission, that measurement error had consequences.

Both findings matter for the same reason. Disparities in care are not only a matter of individual attitude. They are built into beliefs, into schedules, into instruments, and into thresholds, which means they can be found and fixed by audit rather than only preached about.

Why this matters: Look for bias in the tools, the protocols, and the calibration curves, not only in the people. That is where it can be measured and corrected.

Four things that have been tested

Communication research has produced a small set of techniques with reasonable evidence behind them. Here is what each one actually does.

Technique	What it is	What the evidence shows
Full agenda elicitation	Asking what else until the list is complete before working on anything	Reduces late-arising concerns and improves the fit between visit and problem; cheap and reliable
Teach-back	Asking the patient to explain the plan back in their own words	Improves comprehension and recall; evidence on downstream outcomes is more mixed
Decision aids	Structured materials presenting options, benefits, and harms with numbers	Cochrane reviews find improved knowledge, more accurate risk perception, and less decisional conflict; effects on behavior vary
Explanatory model questions	Kleinman's questions about name, cause, fear, and hoped-for treatment	Reliably surfaces information clinicians did not have; hard outcome evidence is limited

The honest pattern across that table is that these techniques improve the informational quality of the encounter, and that the leap from better information to better health outcomes is neither automatic nor well demonstrated. Say so when you teach them. Overclaiming is how good practices get discredited.

Against cultural competence, for mini-ethnography

In 2006 Arthur Kleinman and Peter Benson published a short paper in PLoS Medicine arguing that cultural competency training had gone badly wrong. The failure mode was the trait list: teaching clinicians that patients from group X believe Y and prefer Z. That approach makes culture into a static thing people have, predicts individuals from categories, and ignores the enormous variation inside any group, including variation produced by class, migration history, generation, and religion.

Their alternative is a mini-ethnography of six steps, compressed into what a clinician can actually do. Establish the patient's own ethnic identity and how much it matters to them. Find out what is at stake for this person and their close relations, which is often not what is at stake for the clinician. Reconstruct the illness narrative in the patient's terms. Consider the ongoing stresses and supports in the person's life, which are frequently the operative variable in adherence. Examine how culture is affecting the clinical relationship itself, including the clinician's own professional culture. And finally, ask whether a cultural focus is even useful in this case, because sometimes the barrier is the bus fare.

That last step is the one that distinguishes the approach from its imitations. A method that finds culture in every case is not a method.

Bottom line: Do not learn what a group believes. Learn what this person believes, what is at stake for them, and whether culture is even the relevant variable today.

Common misconceptions

• Interrupting patients is a sign of a bad doctor. The pattern has persisted across decades and health systems, which points at scheduling and workload rather than at individual character.
• A bilingual family member is a reasonable interpreter. Ad hoc interpreters make more clinically consequential errors, and a family member may filter information for reasons of their own.
• Bias in medicine is entirely about individual attitudes. Calibration of instruments, design of protocols, and threshold settings encode disparities too, and those are auditable.
• Cultural competence means learning what each group believes. Trait lists misdescribe individuals and create false confidence; the alternative is asking this patient.
• Good communication reliably improves clinical outcomes. It reliably improves the information available and patient experience; the evidence on hard outcomes is mixed, and pretending otherwise damages the case.

The takeaway

• Three studies across thirty-five years found patients interrupted within roughly eleven to twenty-three seconds and rarely allowed to complete their opening agenda.
• Consultations are asymmetric encounters in a genre the clinician performs professionally and the patient performs rarely; agenda-setting and the closing are the standard failure points.
• Interpretation errors are common and frequently consequential, and ad hoc interpreters are more error-prone than trained ones; language access is a legal requirement in United States federally funded care.
• Bias appears in false beliefs about biology and also in devices such as pulse oximeters, which missed hypoxemia about three times as often in Black patients in a 2020 study.
• Kleinman and Benson's mini-ethnography replaces trait-list cultural competence, and its last step asks whether culture is the relevant variable at all.

Sources

1. Kleinman, A., & Benson, P. (2006). Anthropology in the clinic: The problem of cultural competency and how to fix it. PLoS Medicine, 3(10), e294. doi.org
2. Office of Minority Health. (n.d.). National standards for culturally and linguistically appropriate services in health and health care. U.S. Department of Health and Human Services. minorityhealth.hhs.gov
3. Agency for Healthcare Research and Quality. (n.d.). Health literacy and teach-back. U.S. Department of Health and Human Services. ahrq.gov
4. Beckman, H. B., & Frankel, R. M. (1984). The effect of physician behavior on the collection of data. Annals of Internal Medicine, 101(5), 692-696.
5. Flores, G., Laws, M. B., Mayo, S. J., Zuckerman, B., Abreu, M., Medina, L., & Hardt, E. J. (2003). Errors in medical interpretation and their potential clinical consequences in pediatric encounters. Pediatrics, 111(1), 6-14.
6. Hoffman, K. M., Trawalter, S., Axt, J. R., & Oliver, M. N. (2016). Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites. Proceedings of the National Academy of Sciences, 113(16), 4296-4301.

Five sentences that became evidence

In January 1980 the New England Journal of Medicine published a letter to the editor of about a hundred words. Two researchers, Jane Porter and Hershel Jick, reported that among hospitalized patients given narcotics, they had found only four documented cases of addiction in patients with no history of addiction. It was a note about inpatients on monitored doses. It reported no follow-up, no outpatient data, and no method beyond a database count.

Over the following decades that letter was cited hundreds of times as evidence that opioid addiction was rare. A 2017 analysis in the same journal by Pamela Leung and colleagues counted 608 citations, the majority of them treating it as substantial evidence that addiction risk in pain patients was minimal, and citations rose sharply after 1995, the year sustained-release oxycodone entered the American market. Purdue Pharma's promotional campaign for that drug leaned on the claim that addiction risk was well under one percent.

A hundred words became a fact. The fact became a marketing claim. The marketing claim became a prescribing norm, and the norm became a mortality statistic: the United States has recorded over a hundred thousand drug overdose deaths in a single year, most involving opioids.

Nothing in that sequence is about pharmacology. All of it is about what happens to a substance once it enters social life, which is this lesson's subject.

Medicines as things

Anthropologists borrowed a useful move from the study of commodities: follow the object. A drug is not only a molecule with a mechanism. It is a manufactured thing that is regulated, priced, advertised, prescribed, dispensed, carried home, stored in a drawer, shared with a cousin, split in half, stopped early, and eventually thrown away or flushed. At each of those stages it passes through different hands and acquires different meanings.

Sjaak van der Geest and Susan Reynolds Whyte made the classic argument about why medicines are so attractive as objects. A pill is concrete: it can be held, counted, and given. It is transferable, so it can move without the healer who prescribed it. It concentrates the promise of a cure into something portable. And it gives the sick person a degree of control, which is precisely what illness takes away. Their phrase for this is the charm of medicines, and it explains behavior that clinicians find baffling: why people want a prescription for a viral illness, why a consultation that ends without one feels like a failure, and why medicines circulate socially far outside the paths regulators imagine.

The core of it: A prescription is not only a treatment decision. It is the transfer of a powerful object, and for the patient it is often the point of the visit.

Route, form, and the meaning of strength

Form carries meaning, and the meaning is not the same everywhere.

Ethnographic work across many countries has found injections widely regarded as stronger and more serious than tablets, which in some settings produces demand for injections that offer no therapeutic advantage, sometimes supplied by informal injectionists. The safety consequences are real: WHO has estimated that roughly 16 billion injections are administered worldwide each year, a substantial share of them unnecessary, with unsafe practice contributing to bloodborne infection.

Color, size, and price move in the same way as they do in the placebo research from Lesson 4, and for the same reason. This is not a story about credulous patients in poor countries. Consumers in wealthy countries pay a premium for branded formulations of identical generic molecules, and prefer capsules to tablets for the same active ingredient. The meaning response and the social life of medicines are two descriptions of one phenomenon.

Adherence, and what it actually measures

WHO's 2003 review of adherence to long-term therapies concluded that in high-income countries adherence to treatment for chronic conditions averages around 50 percent. That figure is often presented as a failure of patients. It is at least as much a description of what long-term therapy asks.

Ask what non-adherence actually consists of and the category dissolves into distinct problems: a drug that cost more than the week's food, a regimen that requires refrigeration in a house without power, side effects the patient decided were worse than the disease, a course stopped because the symptoms stopped, a stigmatizing medicine hidden from a spouse and therefore taken irregularly, or a considered decision that the trade is not worth it. Each has a different remedy, and the word non-adherence hides all of them behind an implication of carelessness.

There is also a distinctively anthropological finding here. In many settings, courses are shared. A neighbor with the same symptoms is given half the tablets; a leftover course is saved for the next episode; a pharmacy sells three days of a seven-day course because that is what the customer can pay for. From inside a household that is prudent resource management. From the standpoint of resistance it is a mechanism, which brings us to the strongest case for taking this seriously.

Resistance as a social process

Antimicrobial resistance is usually explained biologically, and the biology is not in doubt: exposure selects for resistant organisms. But every actual exposure has a social route, and the routes are where interventions can act.

The largest estimate to date, from the Global Research on Antimicrobial Resistance project published in The Lancet in 2022, attributed about 1.27 million deaths directly to bacterial antimicrobial resistance in 2019 and associated nearly 5 million deaths with it. The social routes feeding that number include over-the-counter sale of antibiotics where prescription rules are unenforced, prescribing under patient pressure for viral illness, incomplete courses driven by cost, agricultural use in animal feed, and the sale of substandard or falsified products. WHO has estimated that roughly one in ten medical products in low- and middle-income countries is substandard or falsified, and a subtherapeutic dose is close to an ideal resistance-breeding device.

Key idea: Resistance is generated by a biological mechanism running along social pathways. The pathways, not the mechanism, are what policy can change.

Pharmaceuticalization: from treating illness to managing risk

Lesson 6 defined medicalization. Pharmaceuticalization is its narrower cousin: the process by which a widening range of human conditions comes to be managed with drugs.

Joseph Dumit's study of American pharmaceutical marketing describes a specific version of this, in which the target shifts from sick people to healthy people at risk. Once a threshold is defined, on cholesterol, on bone density, on blood pressure, on blood glucose, everyone above the line becomes a candidate for lifelong treatment, and lowering the line by a small amount adds millions of customers overnight. The clinical arguments for such thresholds are often genuinely good; the point is that a market grows or shrinks with an expert committee's decision, and that the committees are not insulated from the industry that benefits.

Two structural facts about the market are worth knowing. Direct-to-consumer prescription drug advertising is permitted in only two countries, the United States and New Zealand, which is why American patients arrive asking for named drugs and patients elsewhere generally do not. And an enormous share of clinical trials has moved offshore to countries where recruitment is faster and participants are more often treatment-naive; Adriana Petryna's fieldwork on that trade documented both the scientific logic of it and the ethical hazard of running trials among people who could not afford the drug being tested.

Who can get the drug

The clearest case in the field's recent history is antiretroviral therapy for HIV. In 2000, a year of first-line treatment cost on the order of ten thousand dollars per patient, which put it out of reach for almost everyone in the countries with the heaviest burden. Generic manufacturing, principally in India, and sustained political pressure changed that: prices for first-line regimens fell by more than 99 percent over the following decade, to under a hundred dollars a year for the most widely used combinations.

The politics were explicit. In 1998, thirty-nine pharmaceutical companies sued the South African government over legislation intended to enable cheaper access to medicines; they withdrew the case in April 2001 amid international pressure. Later that year the World Trade Organization's Doha Declaration on the TRIPS Agreement and Public Health affirmed that intellectual property rules should not prevent members from protecting public health. Brazil and Thailand used compulsory licensing provisions. Millions of people are alive because a price fell, and the price fell because of law, politics, and manufacturing capacity rather than because of any change in the chemistry.

So what?: Access is a property of markets, patents, and politics, not of molecules. The most consequential change in HIV treatment history was a price, not a discovery.

Common misconceptions

• Patients who do not take their medicines have not understood the instructions. Cost, side effects, stigma, storage, and considered disagreement account for most measured non-adherence.
• Preferring injections is a sign of ignorance. Route carries meaning everywhere, including in countries where patients pay extra for branded versions of identical generics.
• Antimicrobial resistance is a purely biological problem. Selection is biological; exposure is organized by markets, prescribing norms, agriculture, and product quality.
• A drug's price reflects the cost of making it. Prices reflect patents, negotiation, procurement volume, and political pressure, as the collapse in antiretroviral prices after 2000 demonstrated.
• Marketing affects only patients, not clinicians. The citation history of a 1980 letter, taken up by industry and repeated in professional literature, shows how a claim can be laundered into medical common sense.

Looking back

• Following a drug through production, regulation, marketing, prescription, distribution, and household use reveals meanings and effects that pharmacology alone cannot explain.
• Medicines are attractive as objects because they are concrete, transferable, and restore a sense of control, which explains demand for prescriptions and the social circulation of drugs.
• Adherence around 50 percent for long-term therapy is a description of what regimens demand, and the category hides distinct problems with distinct remedies.
• Antimicrobial resistance runs along social pathways including unregulated sale, cost-driven partial courses, agricultural use, and substandard products.
• Pharmaceuticalization shifts drug markets from the sick to the at-risk, and access is determined by patents, politics, and manufacturing, as the fall in antiretroviral prices after 2000 showed.

Sources

1. World Health Organization. (n.d.). Antimicrobial resistance. who.int
2. National Institute on Drug Abuse. (n.d.). Opioids. National Institutes of Health. nida.nih.gov
3. U.S. Food and Drug Administration. (n.d.). Drugs. fda.gov
4. Leung, P. T. M., Macdonald, E. M., Stanbrook, M. B., Dhalla, I. A., & Juurlink, D. N. (2017). A 1980 letter on the risk of opioid addiction. New England Journal of Medicine, 376(22), 2194-2195.
5. Whyte, S. R., van der Geest, S., & Hardon, A. (2002). Social lives of medicines. Cambridge University Press.
6. World Health Organization. (2003). Adherence to long-term therapies: Evidence for action. WHO.

Four rooms, one event

Brigitte Jordan spent the 1970s doing something obvious that nobody had done systematically: she watched births in different countries and compared them. Her fieldsites were a Maya community in Yucatan, Mexico; the Netherlands, where home birth with a midwife was then standard; Sweden, with its highly organized hospital maternity care; and the United States, with its obstetric hospital birth.

The physiological event was the same in all four. Almost nothing else was. In the Yucatan household, the laboring woman was surrounded by female kin and a midwife, she moved and changed position freely, and decisions were reached collectively through talk in which her own reports of what her body was doing carried real weight. In the American hospital, she was in a bed, attached to an electronic fetal monitor, and the decisive information about her labor was being read off a paper trace by people who had not been in the room five minutes earlier.

Jordan's term for what she was seeing is authoritative knowledge: in any setting, one kind of knowledge comes to count as the basis for decisions, and other kinds become irrelevant or merely anecdotal. Authoritative knowledge is not necessarily the most accurate knowledge. It becomes authoritative through a social process, and once it is established, everyone in the room, including the people whose knowledge has been displaced, tends to treat the arrangement as natural.

Remember: Authoritative knowledge is the knowledge that counts in a setting. Ask what makes it count, and whose knowledge stopped counting when it did.

Birth as a rite of passage

Robbie Davis-Floyd took the analysis further in her study of American hospital birth, arguing that its standard sequence functions as a rite of passage in the classical anthropological sense, and that what it transmits is a set of core cultural values.

Consider the sequence as ritual rather than as technique. The woman arrives and is placed in a wheelchair, though she walked in. Her clothes are replaced with a gown. She is given an identification band and assigned a room number. An intravenous line is placed, which restricts movement and signals that the body needs supplementation. Continuous monitoring attaches her to a machine whose output others read. Eating is prohibited. In the classic version she gives birth on her back, a position convenient for the attendant and mechanically unhelpful for her.

Davis-Floyd's argument is that each step carries a message: technology is the source of safety, the body is an unreliable machine that requires management, and the institution is in charge. Whether or not you accept the whole argument, the analysis makes a testable prediction, and much of it has been tested. Continuous electronic fetal monitoring in low-risk labor, compared with intermittent listening, has not been shown to reduce cerebral palsy or perinatal death, and it increases cesarean and instrumental delivery rates. Routine supine positioning is not supported. Continuous one-to-one support in labor, by contrast, has good evidence behind it from randomized trials: it increases spontaneous vaginal birth and reduces cesarean delivery, and it costs almost nothing.

That is the strongest possible version of the anthropological point. Some practices persist because they are effective, and some persist because they fit the institution.

Reading the cesarean numbers

Cesarean section is a genuinely lifesaving operation and one of the clearest cases of a procedure whose rate varies far more than its indications do.

Setting	Approximate cesarean rate	What it suggests
United States, 2022	About 32 percent of births	Well above any threshold associated with mortality benefit
Nordic countries	Roughly 16 to 18 percent	Comparable outcomes at half the rate
Brazil, national	Over half of all births, and far higher in private hospitals	Payment structure and physician scheduling as drivers
Parts of sub-Saharan Africa	Under 5 percent in some countries	Unmet need, with deaths from obstructed labor

WHO's 2015 statement on cesarean rates concluded that at population level, rates above about 10 percent are not associated with reductions in maternal and newborn mortality, while emphasizing that every woman who needs the operation should have it. Both halves of that sentence matter. Too few cesareans kills women in obstructed labor. Too many exposes women to major abdominal surgery, and raises risks in subsequent pregnancies, without a measurable population benefit.

Anthropology's contribution is to explain the variation, which is not medical. Fee-for-service payment that pays more for surgery, scheduling that lets a physician plan a delivery, litigation risk that punishes inaction more than action, hospital staffing that cannot support long labors, and in Brazil, a widely documented association between cesarean birth and higher-status private care all push in the same direction.

Deaths that the numbers make visible

WHO estimated about 287,000 maternal deaths worldwide in 2020, the overwhelming majority in low-income countries and most from causes that are treatable where care exists: hemorrhage, hypertensive disorders, sepsis, and unsafe abortion.

Wealthy countries are not exempt, and the United States is the instructive case. The National Center for Health Statistics reported a maternal mortality rate of 32.9 deaths per 100,000 live births in 2021, higher than any other high-income country and elevated by the pandemic, falling to 22.3 in 2022. Within that figure, the rate for Black women in 2021 was 69.9 per 100,000, roughly two and a half times the rate for white women. That gap is not explained by education or income: it persists at every level of both, which is one of the reasons researchers have turned to the accumulated effects of discrimination, differences in the quality of hospitals where women deliver, and the dismissal of reported symptoms in labor and postpartum.

Notice the analytical move being made here, because it recurs in Lesson 12. When a disparity survives adjustment for the obvious individual variables, the explanation has to be sought in structures rather than in individuals.

Stratified reproduction

Anthropologists use the term stratified reproduction for arrangements in which some people's childbearing is supported and celebrated while others' is discouraged, constrained, or prevented outright. The concept forces you to look at reproductive policy as a whole system rather than at one program at a time.

The historical record is unambiguous. The United States Supreme Court upheld compulsory sterilization of institutionalized people in 1927 in Buck v. Bell, and tens of thousands of sterilizations followed under state eugenic laws. In Puerto Rico, sterilization became so widespread by the 1960s that it was known simply as la operación, with roughly a third of women of childbearing age sterilized. During India's Emergency in 1975 to 1977, a mass sterilization campaign performed millions of procedures in a single year under quota pressure, with well-documented coercion. Each of these was carried out by people who believed they were improving public health.

The same logic operates in gentler forms. Which pregnancies get paid leave, which get fertility treatment coverage, which get child benefit, which get a social worker: these are all decisions about whose reproduction a society is willing to support.

What matters here: Reproductive policy is rarely a single rule applied to everyone. Ask, of any measure, whose childbearing it encourages and whose it makes harder.

Choosing, testing, and grieving

Rayna Rapp's long study of amniocentesis in New York followed women through prenatal testing and the decisions it forces. Her phrase for the women she worked with is moral pioneers: ordinary people obliged to make judgments, on short notice and with incomplete information, that no previous generation had to make, about what kind of life is worth continuing. Her finding was that the decisions tracked not intelligence or information but position: religious commitment, class, migration history, and above all whether the woman already had close experience of disability, which frequently made the prospect less frightening rather than more.

Infertility is the mirror image and is understudied because it is silent. Marcia Inhorn's fieldwork in Egypt documented what childlessness costs in a setting where a woman's standing depends heavily on motherhood, and how in vitro fertilization was taken up within religious rules about what may be done. Those rules differ: religious authorities in Iran permitted certain forms of third-party gamete donation from the late 1990s, while Sunni authorities have generally not, and the result has been a cross-border traffic of patients seeking treatment that is permissible somewhere else. Reproductive technology does not arrive in a moral vacuum; it arrives into an existing argument.

Finally, one of the field's most argued-over books. Nancy Scheper-Hughes worked in a shantytown in northeastern Brazil where infant mortality was extraordinarily high, and described mothers who withheld attachment from infants judged unlikely to survive, and who grieved them with restraint, speaking of them as angels who had returned to God. Critics accused her of portraying poor mothers as indifferent. The most important response came from the field itself: when infant mortality in the same community fell sharply in later decades, the practices she had described faded, and mothers grieved as intensely as anywhere. That is strong evidence that what she recorded was an adaptation to catastrophic mortality rather than a cultural trait, and it is a good illustration of why ethnographers return.

Common misconceptions

• Hospital birth practices are all evidence-based. Continuous electronic monitoring in low-risk labor has not been shown to reduce cerebral palsy or perinatal death, and it raises cesarean rates; continuous personal support, which is nearly free, has better trial support than several routine technologies.
• A higher cesarean rate means better care. Above roughly 10 percent at population level there is no demonstrated mortality benefit, and the international variation tracks payment and scheduling more than medical need.
• The United States has low maternal mortality because it is wealthy. It has the highest rate among high-income countries, with a Black to white gap of roughly two and a half times that persists across income and education.
• Coercive reproductive policies belong to the distant past or to authoritarian states. Compulsory sterilization was upheld by the United States Supreme Court in 1927 and practiced for decades, and quota-driven campaigns occurred in living memory.
• Mothers in high-mortality settings do not grieve. When mortality fell in the community Scheper-Hughes studied, the pattern she described disappeared, indicating an adaptation to conditions rather than an absence of feeling.

Summing up

• Authoritative knowledge is the knowledge that counts for decisions in a birth setting, established socially rather than by accuracy alone.
• Davis-Floyd analyzed American hospital birth as a rite of passage transmitting values about technology and the body, and several of its routine practices lack the evidence that continuous labor support has.
• Cesarean rates vary from under 5 percent to over 50 percent between countries, and WHO found no population-level mortality benefit above roughly 10 percent.
• Maternal mortality was about 287,000 deaths worldwide in 2020, and in the United States the Black to white disparity persists across income and education, pointing to structural rather than individual explanation.
• Stratified reproduction names the systematic support of some people's childbearing and the constraint of others', from eugenic sterilization to who receives leave and fertility coverage today.

Sources

1. National Center for Health Statistics. (n.d.). Births and natality; maternal mortality rates. Centers for Disease Control and Prevention. cdc.gov
2. World Health Organization. (n.d.). Maternal health. who.int
3. Eunice Kennedy Shriver National Institute of Child Health and Human Development. (n.d.). Pregnancy and labor and delivery. National Institutes of Health. nichd.nih.gov
4. Jordan, B. (1993). Birth in four cultures: A crosscultural investigation of childbirth in Yucatan, Holland, Sweden, and the United States (4th ed., rev. R. Davis-Floyd). Waveland Press.
5. Davis-Floyd, R. (1992). Birth as an American rite of passage. University of California Press.
6. Rapp, R. (1999). Testing women, testing the fetus: The social impact of amniocentesis in America. Routledge.

A town where deafness was not a disability

In the nineteenth century, in Chilmark at the western end of Martha's Vineyard, roughly one person in twenty-five was born deaf. The rate for the United States as a whole at the time was on the order of one in five thousand seven hundred. The cause was a recessive gene concentrated by generations of intermarriage in an isolated island community descended largely from a small group of English settlers.

Nora Ellen Groce went to the Vineyard in the 1970s and 1980s to interview the oldest surviving residents about what that had been like. Her finding, and the title of her book, is that everyone there spoke sign language: hearing islanders were bilingual, signing was used in shops, on boats, at church, and in ordinary conversation, and deaf residents farmed, married hearing spouses, held town office, and were as prosperous as their neighbors. When Groce asked elderly informants about the handicaps of the deaf people they had known, several were puzzled by the question. One of them, asked what was wrong with a particular man, said that there was nothing wrong with him, he was just deaf.

Hold onto that answer. The impairment was identical to deafness anywhere else. The disability was absent, because the environment had absorbed it. That single case is the strongest empirical support anyone has offered for the claim this lesson examines.

Three models, and what each gets right

The argument in disability studies is usually staged as a contest between two models, and the honest version has three.

The medical or individual model locates disability in the body. A person cannot walk; the problem is the spinal cord; the response is treatment, rehabilitation, or a prosthesis, and success is measured by how closely the person approximates typical function. This model built rehabilitation medicine and it has saved and improved enormous numbers of lives. Its failure is that it treats the environment as fixed and the body as the variable, which is a choice rather than a fact.

The social model, formulated by British disability activists in the 1970s and given its name in the 1980s, reverses the assignment. It distinguishes impairment, a bodily difference, from disability, the disadvantage imposed by a society organized around people without that impairment. On this account a wheelchair user is not disabled by their legs but by the step at the entrance, and the intervention is a ramp rather than a cure. This model produced the disability rights movement, the slogan nothing about us without us, and legislation including the Americans with Disabilities Act of 1990, and it is why cities now have curb cuts, which turn out to help parents with strollers and travelers with suitcases as well.

The interactional model, associated with Tom Shakespeare among others, argues that the strong social model overcorrected. Impairment is not a neutral difference in all cases: chronic pain, fatigue, breathlessness, and progressive conditions cause suffering that no amount of accessible design removes, and pretending otherwise leaves people with those conditions unrepresented by their own movement. WHO's International Classification of Functioning, Disability and Health, published in 2001, encodes something close to this position, describing functioning as an interaction between health conditions, body structures, activities, participation, and environmental factors.

Model	Where the problem is	The intervention	Strongest objection
Medical	In the body	Treat, rehabilitate, restore function	Treats the environment as fixed and the person as the thing to change
Social	In the environment and its arrangements	Remove barriers, redesign, legislate	Understates impairment effects such as pain and fatigue
Interactional	In the relation between the two	Both, according to the case	Harder to turn into a political slogan or a single legal test

The upshot: Martha's Vineyard shows the social model at its most powerful. Progressive neurological disease shows its limits. A framework that can hold both is more useful than one that can only hold your favorite case.

The category itself is not universal

Anthropology's specific contribution is the finding that many societies have no general category corresponding to disability at all. Benedicte Ingstad and Susan Reynolds Whyte's comparative work found communities in which people distinguished specific conditions, being blind, being unable to walk, having fits, without grouping them into a single class of persons defined by incapacity. The category disabled is itself a cultural artifact, produced in part by bureaucracies that needed a class of people to whom a rule could apply.

Ingstad and Whyte are also careful about a myth that students often arrive with. It is not true that small-scale or non-Western societies uniformly treated disabled people well. The record is mixed, and includes exclusion, infanticide, and treatment as evidence of witchcraft, alongside full inclusion. The useful question is not whether a society was kind but what its economy, its household structure, and its explanatory system did with a particular kind of difference. A community whose work is agricultural and collective can absorb a slow worker; one paid by piecework cannot.

Sign language communities give the clearest comparative evidence. Martha's Vineyard is not unique. In an Al-Sayyid Bedouin community in the Negev, a high rate of congenital deafness led to the emergence of an indigenous sign language within a few generations, used by deaf and hearing villagers alike and studied by linguists since the 1990s. Where deafness is common enough and the community is dense enough, the environment adapts, and the disability largely disappears.

Deaf culture and the argument about cochlear implants

The strongest form of the claim that disability is a social category comes from Deaf communities themselves. Many deaf people, conventionally marked by a capital D in Deaf, describe themselves not as impaired but as members of a linguistic and cultural minority. American Sign Language and other sign languages are full natural languages with their own grammar, established in linguistics from William Stokoe's work in 1960, and they support literature, humor, poetry, and history.

On that view, a technology that aims to eliminate deafness is not straightforwardly a benefit; it is a threat to a language community, comparable to a policy of assimilating a linguistic minority. That is the background to the long dispute over pediatric cochlear implantation, which is most effective when performed early, meaning at an age when the child cannot participate in the decision and the parents are usually hearing people with no connection to Deaf community life.

The dispute has softened somewhat, with more families pursuing implantation alongside sign language rather than instead of it, and it has not disappeared. What made the political standing of Deaf communities visible was the Deaf President Now protest at Gallaudet University in March 1988, when students shut the university down over the appointment of a hearing president and won, with I. King Jordan becoming the institution's first deaf president.

Key idea: Whether a bodily difference is an impairment to be corrected or an identity to be sustained is not settled by the biology. It is settled by an argument, and the people with the condition are parties to it.

Stigma, and the three bodies

Erving Goffman's 1963 analysis of stigma remains the most used tool here. His central point is that stigma is not a property of a person but of a relationship: an attribute becomes discrediting only in a setting that expects something else. He distinguished visible stigma, where the discrediting attribute is apparent and the task is managing tension, from concealable stigma, where the task is managing information, deciding who knows and when. Anyone with a condition they choose whether to disclose at a job interview knows the second problem intimately.

Nancy Scheper-Hughes and Margaret Lock's framework of three bodies is useful for keeping the levels apart. There is the individual body, as lived and experienced. There is the social body, the body as a symbol used to think about society. And there is the body politic, the body as an object of regulation, surveillance, and control by states and institutions. A disabled body is all three at once: a lived body with its own capacities and pain, a symbol in arguments about dependency and worth, and an administrative object assessed for benefits eligibility.

The scale of it

WHO's 2022 global report on health equity for persons with disabilities estimated that about 1.3 billion people, roughly 16 percent of the world's population, experience significant disability. The report's central finding is that disabled people face worse health outcomes for reasons that are largely not caused by their impairments: inaccessible facilities, unaffordable transport, clinicians who address the companion rather than the patient, and screening programs that exclude people who cannot use the equipment. A related WHO and UNICEF report estimated that around 2.5 billion people need at least one assistive product, and that close to a billion of them lack access.

Those numbers make the practical point better than the theory does. Most of the health disadvantage attached to disability is produced by arrangements that could be built differently.

Bottom line: Disability is common, and most of its health consequences are made by design decisions rather than by bodies.

Common misconceptions

• The social model claims impairments are not real. It claims that disability, the disadvantage, is produced socially. The interactional critique exists precisely because the strong version can slide into denying impairment effects.
• Traditional societies treated disabled people better. The comparative record is mixed and includes exclusion and worse; romanticizing it is a way of avoiding the actual question about economy and household structure.
• Deaf people who decline cochlear implants are refusing treatment. Many describe deafness as membership in a language community rather than a deficit, which changes what counts as a benefit.
• Accessibility measures help only disabled people. Curb cuts, captions, and step-free access are used constantly by people who do not identify as disabled, which is the standard argument for universal design.
• Disability is a fixed category found in every society. Many societies name specific conditions without grouping them into a single class of incapable persons; the general category is partly an administrative product.

What to remember

• On nineteenth-century Martha's Vineyard, hereditary deafness was common and the whole community signed, so the impairment existed while the disability largely did not.
• The medical model locates the problem in the body, the social model in the environment, and the interactional model in the relation between them; each has a serious objection against it.
• Many societies lack a general category of disability, and the comparative record on treatment is mixed rather than uniformly kind.
• Deaf communities argue that sign languages make them a linguistic minority rather than an impaired population, which reframes cochlear implantation as a political as well as clinical question.
• WHO estimates about 1.3 billion people experience significant disability, and most of their excess health disadvantage comes from inaccessible systems rather than from impairment itself.

Sources

1. World Health Organization. (n.d.). Disability. who.int
2. U.S. Department of Justice. (n.d.). Americans with Disabilities Act. ada.gov
3. National Institute on Deafness and Other Communication Disorders. (n.d.). American Sign Language. National Institutes of Health. nidcd.nih.gov
4. Groce, N. E. (1985). Everyone here spoke sign language: Hereditary deafness on Martha's Vineyard. Harvard University Press.
5. Ingstad, B., & Whyte, S. R. (Eds.). (1995). Disability and culture. University of California Press.
6. Shakespeare, T. (2014). Disability rights and wrongs revisited (2nd ed.). Routledge.

Death arrives by committee

In August 1968 a surgeon named Juro Wada performed Japan's first heart transplant, in Sapporo. Questions followed almost immediately about whether the donor had really been dead and whether the recipient had really needed a new heart. Wada was accused of murder. He was never brought to trial, and the case became a national scandal that shaped Japanese attitudes toward transplantation for a generation. Japan did not pass a law permitting organ procurement from brain-dead donors until 1997.

That same year, 1968, an ad hoc committee at Harvard Medical School published a report proposing that irreversible coma be recognized as a new criterion for death. The proposal was adopted quickly across North America and much of Europe, and by 1981 the United States had a uniform statute defining death as either irreversible cessation of circulatory and respiratory function or irreversible cessation of all functions of the entire brain.

Margaret Lock's comparative study of these two trajectories asks the obvious question: why did the same technology, the same physiology, and the same argument produce rapid acceptance in one society and thirty years of refusal in another? Her answer is not that Japanese people were unscientific. It is that brain death requires you to accept that a warm, breathing, pink body with a heartbeat is a corpse, and whether that is thinkable depends on where personhood is understood to reside, on who has authority over a body at the moment of death, and on how much the public trusts the profession asking for the organs.

Why this matters: Death is a biological event and also a social determination, and the second part is decided by committees, statutes, and public trust. Where those differ, the moment of death differs.

Dying as a process, and the work of the living

Robert Hertz made the foundational anthropological argument in 1907, studying societies with secondary burial, where the corpse is buried or exposed, allowed to decompose, and then exhumed for a second ceremony months or years later. Hertz argued that these societies were doing openly what all societies do: treating death as a passage that takes time. The body decays, the soul travels, and the survivors are gradually reassembled into a group that no longer contains the dead person. The intense first phase is dangerous and polluting; the second ceremony ends it.

Read modern practice through Hertz and the pattern is visible. There is a moment of clinical death, then a period of arrangements, then a funeral, then a longer period of mourning with its own rules about clothing, work, and remarriage, and finally reintegration, sometimes marked by an anniversary. Wills, probate, and the closing of accounts are part of the same process: the administrative dissolution of a social person, which in a bureaucratic society takes months.

The clinical implication is that families are doing work that the institution often does not see. Time at the bedside, the presence of specific relatives, the handling of the body afterward, and permission for particular rites are not sentimental extras. They are how the transition gets accomplished.

Getting old in different places

Population ageing is the largest quiet fact in global health. WHO projects that by 2030 one person in six worldwide will be aged sixty or over, with the population aged sixty and above rising from about one billion in 2020 to 1.4 billion in 2030 and around 2.1 billion by 2050. Japan is furthest along, with close to thirty percent of its population aged sixty-five or over.

An older generation of theory held that the status of old people falls as societies modernize, because the young acquire skills and independent incomes and elders lose control of land and knowledge. The idea has some support and many exceptions, and comparative work has complicated it considerably.

Sarah Lamb's fieldwork in West Bengal describes an ideal in which ageing well means gradually loosening one's ties to the world and being cared for by kin, with dependence understood as appropriate rather than shameful. Set that beside the North American ideal Lamb has also studied, in which ageing well means staying active, independent, productive, and as much like a middle-aged person as possible. The second ideal has real benefits, since activity and social connection are genuinely protective, and it also has a cost that is rarely stated: it defines frailty and dependence as failures, which is a difficult message to receive when you are frail and dependent, as most people eventually are.

In short: Successful ageing is a cultural ideal, not a neutral clinical standard, and every version of it implies a verdict on the people who cannot meet it.

Where people die, and who decides

Sharon Kaufman spent years observing American hospitals and found an institution poorly designed for the thing it does most often. Hospitals run on trajectories: a patient is expected to improve and leave, or to die, and the system struggles with people who do neither. Her account describes the constant pressure to decide, the difficulty of stopping treatment once it has started, and the way that a technology available at the bedside tends to be used, because the alternative requires an explicit decision that someone must own.

The statistics have moved. In the United States, home overtook the hospital as the most common place of death in 2017, at about 30.7 percent of deaths against 29.8 percent in hospitals, the first such crossover since the mid-twentieth century. That reflects the growth of hospice, which began with Cicely Saunders and the opening of St Christopher's Hospice in London in 1967, and which in the United States became a funded Medicare benefit in 1982. Roughly half of Medicare beneficiaries who die are enrolled in hospice at death, but the median length of enrollment is measured in a couple of weeks, which means a large share arrive when there is very little time left to use what hospice provides.

What the trials found, which is not what people expected

End-of-life care is an area where the evidence is unusually clear about which reforms work.

The SUPPORT study, published in 1995, was an ambitious two-phase project in five American teaching hospitals. It first documented poor communication, aggressive treatment, and frequent pain among seriously ill patients. Then it ran a substantial intervention: prognostic information delivered to physicians, plus a skilled nurse to facilitate communication with patients and families. The intervention changed essentially nothing. Documentation improved; the timing of do-not-resuscitate orders, reported pain, and days spent in intensive care before death did not.

That result is worth sitting with. Information and goodwill, added on top of an unchanged institution, did not shift behavior. It suggests the constraints are structural, which is precisely what Kaufman's ethnography found from the inside.

Contrast the 2010 trial by Jennifer Temel and colleagues, which randomized patients with newly diagnosed metastatic lung cancer to standard oncologic care or to standard care plus early palliative care from the time of diagnosis. The palliative care group reported better quality of life and fewer depressive symptoms, received less aggressive treatment at the end of life, and lived longer, with median survival of 11.6 months against 8.9. Adding a service that changed how care was organized worked where adding information to existing routines had not.

The core of it: Reforms that only add information to an unchanged institution tend to fail. Reforms that change who is in the room and what their job is can succeed, and occasionally they extend life as well as improve it.

Good deaths, and the argument about hastening them

Anthropologists have documented a wide range of ideals of a good death, and the variation is instructive. A common Anglo-American ideal involves awareness, time to say goodbye, being at home, and being free of pain. Elsewhere the emphasis falls on dying without burdening one's family, on dying suddenly and cleanly, on dying with the correct rites performed, or on dying in a particular place. In Japan, wishes for a sudden death that avoids a long period of dependence have been widely documented and are the near opposite of an ideal centered on a long, aware farewell.

Assisted dying is now legal in a growing number of jurisdictions, beginning with the Netherlands and Belgium in 2002 and, in the United States, with Oregon's Death with Dignity Act, passed by ballot in 1994 and in effect from 1997. Canada legalized medical assistance in dying in 2016. Oregon's state reporting is the longest-running data series available, and one of its most consistent findings is worth knowing because it surprises people: the reasons participants most often give are loss of autonomy and decreasing ability to take part in activities that make life enjoyable, with inadequate pain control cited far less often. That is a finding about what people fear, and it points at dependence rather than at agony.

The debate remains genuinely open, with the strongest arguments on each side resting on different things: on autonomy and the relief of suffering on one side, and on the risk of pressure toward death among people who are poor, disabled, or without support on the other. Disability rights organizations have been among the most consistent critics, and their objection is not religious; it is that a society which has already decided some lives are burdensome cannot be trusted to offer this choice neutrally.

Common misconceptions

• Brain death is a purely medical fact with no social component. The criterion was proposed by a committee in 1968 and adopted at very different times in different countries, for reasons involving personhood, family authority, and trust.
• Advance directives solve end-of-life decision making. The SUPPORT study's large intervention, including prognostic information and skilled facilitators, produced essentially no change in the outcomes it targeted.
• Palliative care means giving up and shortens life. In the Temel trial, early palliative care alongside standard oncology improved quality of life and was associated with longer median survival.
• Everyone wants a slow, aware death at home. Ideals of a good death vary widely, and a quick death that spares the family is a strongly held preference in many settings.
• People choose assisted dying mainly to escape pain. Oregon's long-running reports show loss of autonomy and inability to participate in enjoyable activities cited far more often than inadequate pain control.

Recap

• Brain death was proposed in 1968 and became law in the United States by 1981, while Japan did not permit procurement from brain-dead donors until 1997, a difference in social determination rather than in biology.
• Hertz showed that death is a process for the living as well as the dying, accomplished through phases of separation, transition, and reintegration that clinical settings often fail to accommodate.
• Population ageing is rapid worldwide, and successful ageing is a cultural ideal whose North American version treats dependence as failure.
• Home overtook hospital as the most common place of death in the United States in 2017, and hospice enrollment, though common, is frequently very late.
• SUPPORT showed that information added to an unchanged institution changed nothing, while the Temel trial showed that early palliative care improved quality of life and was associated with longer survival.

Sources

1. World Health Organization. (n.d.). Ageing and health. who.int
2. National Institute on Aging. (n.d.). End of life and advance care planning. National Institutes of Health. nia.nih.gov
3. National Cancer Institute. (n.d.). Palliative care in cancer. National Institutes of Health. cancer.gov
4. Lock, M. (2002). Twice dead: Organ transplants and the reinvention of death. University of California Press.
5. Kaufman, S. R. (2005). And a time to die: How American hospitals shape the end of life. Scribner.
6. Temel, J. S., Greer, J. A., Muzikansky, A., Gallagher, E. R., Admane, S., Jackson, V. A., Dahlin, C. M., Blinderman, C. D., Jacobsen, J., Pirl, W. F., Billings, J. A., & Lynch, T. J. (2010). Early palliative care for patients with metastatic non-small-cell lung cancer. New England Journal of Medicine, 363(8), 733-742.

A dam, a hillside, and two funerals

In 1956 engineers closed the Peligre Dam across the Artibonite River in central Haiti. The reservoir behind it drowned the valley floor, which held the best farmland in the region, and the families who had farmed it moved up onto the dry, steep slopes above the new waterline. They called themselves water refugees. They received no compensation. The electricity went to Port-au-Prince and to the agricultural interests downstream.

Twenty-seven years later a young American named Paul Farmer arrived in one of those hillside settlements. He stayed, learned Haitian Creole, and in 1987 helped found Partners In Health, whose Haitian sister organization built a clinic at Cange, on the ridge above the reservoir. Farmer spent the next three decades arguing one thing in many forms, and the argument began with two deaths he wrote about at length.

Acephie Joseph was born to a displaced family on that hillside. Her parents lost their land to the reservoir. She left school because there was no money, took work in a town where soldiers were the men with reliable incomes, and formed a relationship with one of them. He died of AIDS. So, a few years later, did she.

Chouchou Louis, from the same region, was riding in the back of a truck when he made a remark about the state of the roads. A soldier in civilian clothes was listening. Chouchou was arrested, beaten over a period of days, and released; he died shortly afterward of his injuries.

Farmer put the two stories side by side deliberately. One death looks like an infection and the other looks like an assault, and the point of the pairing is that the difference matters less than it appears. Neither person could have chosen their way out. The forces that killed them were older than they were: a dam, a debt, an army, a set of rules about who eats and who does not.

The upshot: Structural violence is the claim that social arrangements, not accidents, do a large share of the killing, and that you can trace the path from the arrangement to the body.

Where the phrase came from, and what it is doing

The term is not Farmer's. Johan Galtung, a Norwegian peace researcher, introduced it in a 1969 article in the Journal of Peace Research, arguing that violence should be defined as anything that keeps people below what they could otherwise achieve. On that definition, a person who dies of a treatable disease in a country that could afford the treatment has been subjected to violence, even though nobody swung anything. The violence is built into the structure, hence the name, and its distinguishing feature is that there is no identifiable perpetrator to prosecute.

Farmer's second source was theological rather than academic. Liberation theology, developed in Latin America from the late 1960s and associated above all with the Peruvian priest Gustavo Gutierrez, holds that a moral account of the world should begin from the position of the poor. Farmer was explicit that he took the phrase preferential option for the poor from that tradition and used it as a research principle: when you must choose whose account of an event to start from, start with the person who has the least power in it.

The gradient nobody expected

The strongest evidence for the general claim did not come from Haiti. It came from Whitehall, and it came as a surprise.

In the 1960s the received wisdom held that heart disease was an executive's illness, produced by the pressure of decisions. Michael Marmot and colleagues followed a large cohort of British civil servants and found the reverse. In the analysis published in 1978, among roughly seventeen thousand men aged forty to sixty-four, mortality from coronary heart disease rose steadily as employment grade fell, with the lowest grade running at about three times the rate of the highest.

Two things about that result are hard to explain away. First, everyone in the study had a job, an income, and access to the National Health Service, so this is not a finding about destitution. Second, the pattern was a gradient rather than a cliff. Administrators did better than professionals, who did better than clerical staff, who did better than messengers. Each step down the hierarchy cost something, including steps well above any plausible poverty line.

Whitehall II, launched in 1985, recruited over ten thousand civil servants including women, and confirmed the gradient across a wide range of outcomes. It also produced the finding that has travelled furthest: low control over one's own work predicted illness better than the demands of the job did. It is not the pressure of decisions that hurts. It is having to carry out someone else's.

The American data are cruder and more extreme.

Study	Who	Compared by	Result
Whitehall I, reported 1978	About 17,500 male British civil servants	Employment grade	Lowest grade about three times the coronary mortality of the highest
Whitehall II, from 1985	Over 10,000 civil servants, women included	Grade plus detailed measures of the job	Gradient confirmed; low job control a strong predictor
Chetty and colleagues, 2016	United States population, tax and death records, 2001-2014	Household income percentile	Men in the richest one percent outlived men in the poorest one percent by 14.6 years; for women the gap was 10.1 years

That last study added a detail worth holding onto. Among the poorest Americans, life expectancy varied substantially depending on which city they lived in, by several years. Being poor was not one condition with one outcome. It was a condition whose consequences depended on what the surrounding place did about it, which is exactly what a structural argument predicts.

Worth holding on to: The health gradient runs the whole length of the social scale, not just at the bottom, and it responds to local arrangements. Both facts are difficult for any explanation resting on individual choices alone.

How the outside gets inside

A correlation is not a mechanism, and this is where a careless version of the argument stops. There are at least four pathways, and they do different work.

Exposure. Poorer people are in more hazardous places for more hours. That covers occupational injury, cold and damp housing, traffic, and air: WHO attributes millions of deaths a year to household air pollution from cooking with solid fuels, a burden that falls almost entirely on low-income households and disproportionately on women and small children. This pathway needs no biology beyond the obvious.

Access, and what treatment demands of you. The relevant question is rarely whether a drug exists. Standard tuberculosis treatment runs six months, with the early phase often observed daily. That regimen quietly assumes a fixed address, transport, an employer who tolerates a morning appointment, and food, because the drugs are hard to take on an empty stomach. A person sleeping in a shelter and working shifts is not refusing treatment when the course collapses. The regimen was designed for a life they do not have.

Chronic stress. The hypothesis is that sustained activation of the stress response, mediated by cortisol and the sympathetic nervous system, has a cumulative physiological cost, which Bruce McEwen named allostatic load. Robert Sapolsky's long study of olive baboons in Kenya found that subordinate males carried higher baseline cortisol than dominant ones, in a population where rank is social and the food supply is not the issue. Be careful here. The animal work is solid and the human work is suggestive, but how much of the human gradient this pathway explains is genuinely unsettled, and honest researchers argue about the size of the effect.

Behavior, and where behavior comes from. Smoking, diet, and exercise really do differ by social position, and they really do affect health. The Whitehall investigators tested the obvious objection directly: adjust for smoking, blood pressure, cholesterol, and the other standard risk factors, and the grade difference shrinks but does not go away, with the classical factors accounting for well under half of it. So the choices matter and they are not the whole story, and the distribution of the choices is itself something to explain.

The case against, in three parts

Structural violence is one of the most cited ideas in the field and also one of the most criticized, including by people who share its politics. Three objections deserve a serious answer.

It explains too much. If the dam, the debt, the army, the gender norms, and the virus are all violence, the word has stopped sorting anything. Critics who responded to Farmer's 2004 article in Current Anthropology pressed this hard: a concept that covers every bad outcome cannot tell you which lever to pull, and calling a structure violent without naming an agent can feel like an accusation that is also unfalsifiable. This is the objection with the most force, and the answer to it is discipline rather than retreat, as the next section describes.

The economics may not hold. Richard Wilkinson's influential claim was that societies with wider income inequality have worse health on average, independent of how rich they are. Angus Deaton, who won the Nobel Memorial Prize in economics in 2015, has argued at length that this relationship is fragile: it depends heavily on which countries and which American states are included, and much of the apparent effect can be accounted for by other things. Deaton's position is not that poverty is harmless. It is that absolute income, institutions, and above all the diffusion of medical and public health knowledge do most of the explanatory work, and that inequality as such is a weaker lever than its advocates claim. Anyone who cannot state this objection has not understood the debate.

It turns people into victims. Didier Fassin has traced how the language of suffering came to organize humanitarian politics, and warned that compassion is a poor substitute for rights: the sufferer is heard as a body in pain rather than as a citizen with a claim. Joel Robbins made a related argument in 2013 about the discipline itself, coining the phrase the suffering subject for anthropology's tendency to write about people mainly as sites of damage, which crowds out everything else in their lives. Neither writer denies that the suffering is real. Both ask what is lost when it becomes the only thing an ethnographer reports.

What Farmer put up against the objections

The most convincing reply Farmer made was not an argument. It was an outcome.

Through the 1990s the consensus in international tuberculosis control was that treating multidrug-resistant TB in poor countries was not cost-effective. Second-line drugs were expensive and toxic, treatment ran for two years, and the money was thought to be better spent on standard short-course therapy for ordinary TB. Partners In Health took a different view in Carabayllo, a poor district on the northern edge of Lima, where an outbreak of resistant disease had appeared among people whom the standard program had already failed. From 1996 the team treated them with individualized second-line regimens delivered by community health workers.

The results, published in the New England Journal of Medicine in 2003, reported a probability of cure of about four in five among the cohort. That number mattered because the cost-effectiveness argument had rested on an empirical prediction, namely that such treatment would not work in such a setting, and the prediction was wrong. In 2000 the Green Light Committee began negotiating second-line drug prices down for programs that met quality standards, and treatment of resistant TB moved from the category of the unaffordable into WHO policy.

Bottom line: The strongest version of the structural argument is not moral assertion. It is a specific prediction that an arrangement is producing a specific outcome, followed by a change to the arrangement and a measurement of what happened.

Four questions that keep the idea honest

Here is a discipline you can apply to any case, designed to answer the first objection above. Take Haiti's cholera epidemic, which began in October 2010, ten months after the earthquake, and which had produced more than eight hundred thousand reported cases and roughly nine thousand eight hundred deaths by the time transmission stopped. Genomic and epidemiological evidence traced the strain to a United Nations peacekeeping contingent, and in 2016 the Secretary-General publicly apologized for the organization's role.

1. Name the structure precisely. Not poverty. The absence of piped, treated water and sewerage for most of the rural population, and a sanitation system at a peacekeeping base that discharged into a tributary of the Artibonite.
2. Name the pathway to the body. Fecal contamination of a river used for drinking, washing, and irrigation; ingestion of Vibrio cholerae; profuse diarrhoea; death from dehydration within hours if oral or intravenous rehydration is not reached in time.
3. Name the counterfactual, and find a real one. Cholera does not establish itself where water is treated. The organism had been absent from Haiti for a century; the introduction was new, the vulnerability was not.
4. Name the lever, and who can pull it. Water and sanitation infrastructure, oral cholera vaccine, rehydration points within reach of villages, and sanitation standards for deployed troops. Each has an owner.

Run those four steps and the concept does work. Skip them and it becomes a way of saying that things are unfair, which everyone already knew.

Common misconceptions

• Structural violence is a claim that individuals bear no responsibility. It is a claim about the distribution of options. Chouchou made a remark and Acephie formed a relationship; the analysis is about what the range of available choices had been narrowed to.
• The health gradient is really just poverty. Whitehall found a gradient among salaried civil servants with universal health coverage, with each step down the hierarchy carrying a cost well above any poverty threshold.
• Health differences disappear once you adjust for smoking and diet. In Whitehall the standard risk factors explained under half of the difference between grades.
• Everyone in the field accepts the concept. It draws serious objections on analytical grounds, on the economics of inequality and health, and on what it does to the people it describes.
• Stress hormones are the proven mechanism. Allostatic load is a plausible and partly supported pathway, not a settled account, and the size of its contribution to the human gradient is disputed.

Where this leaves us

• Structural violence, from Galtung in 1969 and liberation theology by way of Farmer, names harm produced by social arrangements rather than by identifiable actors, and asks you to trace the path from the arrangement to the body.
• Whitehall found a smooth gradient in coronary mortality across employment grades among insured, employed men, and Whitehall II identified low control over work as a strong predictor.
• American income data show a gap of 14.6 years in male life expectancy between the top and bottom income percentiles, with the outcomes of poverty varying by city.
• Four pathways carry social position into a body: exposure, what treatment demands of a patient, chronic stress, and behavior that is itself socially patterned.
• The serious objections are that the concept explains too much, that the inequality-and-health economics is contested, and that it can reduce people to their suffering; the reply with the most weight is the Lima MDR-TB cohort, where a cost-effectiveness prediction was tested and failed.

Sources

1. Farmer, P. E., Nizeye, B., Stulac, S., & Keshavjee, S. (2006). Structural violence and clinical medicine. PLoS Medicine, 3(10), e449. doi.org
2. World Health Organization. (n.d.). Social determinants of health. who.int
3. Office of Minority Health. (n.d.). Minority population profiles and health disparities data. United States Department of Health and Human Services. minorityhealth.hhs.gov
4. Galtung, J. (1969). Violence, peace, and peace research. Journal of Peace Research, 6(3), 167-191.
5. Farmer, P. (2003). Pathologies of power: Health, human rights, and the new war on the poor. University of California Press.
6. Marmot, M. (2004). The status syndrome: How social standing affects our health and longevity. Times Books.
7. Deaton, A. (2013). The great escape: Health, wealth, and the origins of inequality. Princeton University Press.
8. Mitnick, C., Bayona, J., Palacios, E., Shin, S., Furin, J., Alcantara, F., Sanchez, E., Sarria, M., Becerra, M., Fawzi, M. C. S., Kapiga, S., Neuberg, D., Maguire, J. H., Kim, J. Y., & Farmer, P. (2003). Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. New England Journal of Medicine, 348(2), 119-128.

Twenty-eight thousand cases, and a hollow tree

In December 2013, in the village of Meliandou in Gueckedou prefecture, southeastern Guinea, a two-year-old boy fell ill and died within days. His sister, his mother, and his grandmother followed. Investigators later concluded that the likeliest source was contact with bats roosting in a hollow tree near the village. The nearest laboratory capable of confirming Ebola was in another country. Three months passed before the outbreak was identified, and by then it had reached Conakry, a capital city of two million people, and had crossed into Liberia and Sierra Leone.

By the time transmission ended, the West African outbreak had produced roughly 28,600 reported cases and more than 11,300 deaths, more than every previous Ebola outbreak in history combined. WHO declared it a public health emergency of international concern on 8 August 2014, eight months after the first death.

Everything that made that epidemic hard to stop was social. The virus was the same virus. What was different was a border region where three countries meet and families live on both sides of every line, a health system with a few dozen doctors for millions of people, two recent civil wars, and a set of funeral obligations that put the living in contact with the most infectious material a body ever produces.

The point: An epidemic is a biological event that runs on social rails. The pathogen sets the mechanism; the society determines the route, the speed, and who is standing in the way.

A shape you can recognize

The historian Charles Rosenberg argued in 1989, writing about AIDS, that epidemics move through a recognizable dramatic structure, and once you have seen it you will see it every time.

Progressive revelation. Societies are slow to admit an epidemic, because admitting it is costly. Cases accumulate and are explained away as something familiar. In Guinea the early deaths were attributed to cholera and to Lassa fever, both endemic and both plausible. Denial is not stupidity here; it is the default of any system that has seen many alarms and few epidemics.

Managing randomness. Once the thing is undeniable, people demand an explanation of why it struck this house and not that one. Biomedicine offers probability, which is emotionally useless. Everyone else offers a story: sin, sorcery, foreigners, a government plot, a laboratory. Every epidemic in recorded history has produced accusations, and the accused are usually people who were already suspect.

Negotiating public response. Authorities act, usually with the blunt instruments they have. The word quarantine comes from the Venetian quaranta giorni, forty days, the isolation imposed on arriving ships in the fourteenth century after Ragusa introduced a thirty-day version in 1377. The instrument is six centuries old and its politics have not changed much: it is always applied to somebody, and that somebody notices.

Subsidence and retrospection. Transmission falls, attention moves on, and the society tells itself a story about what happened. The story is usually flattering to whoever tells it, and the reforms it recommends are usually the ones that were already on someone's agenda.

The burial problem

Ebola concentrates in bodily fluids, and a corpse is at its most infectious in the hours after death. In much of the affected region, the obligations of a funeral include washing the body, dressing it, and touching it in farewell, often by named relatives with specific roles. Those obligations are not optional courtesies. They determine whether a person is properly sent, whether the family has behaved honourably, and in many accounts whether the dead will trouble the living.

The early response treated this as an obstacle to be removed. Burial teams in protective suits took bodies away, sometimes without telling the family where, and buried them in ground the family had not chosen. It is difficult to design a policy better calculated to produce resistance. Rumours spread that the teams were harvesting organs, that the treatment centres were where people were taken to be killed, and that the whole thing had been invented to attract foreign money. On 16 September 2014, in the Guinean village of Womey, eight members of a health education delegation were killed.

The correction came from taking the funeral seriously as a system with requirements. WHO issued a protocol for safe and dignified medical burials in late 2014, developed with religious leaders and anthropologists, which kept the infection control and gave back what could be given: family members present at the graveside, prayers said by the appropriate people, the face visible where it could be made safe, the grave in a known and marked place, the body wrapped rather than hidden. Compliance improved substantially where teams worked this way, not because people had been persuaded that Ebola was real, but because they had been offered a funeral they could accept.

What matters here: The choice was never between infection control and culture. It was between an infection control policy that made a funeral impossible and one that made a different funeral possible, and only the second one worked.

What anthropologists actually did

This was not the field's first outbreak. Barry Hewlett was invited onto a WHO Ebola response team in Gulu, northern Uganda, in 2000, the first anthropologist to hold that role, and found that the Acholi already had a category for epidemic illness with its own protective rules, including limiting contact with the sick, suspending burial rites, and quarantining affected households. Local practice contained public health logic that the response team had assumed it would have to supply.

In 2014 that experience was mobilized quickly. The Ebola Response Anthropology Platform, set up in the autumn of 2014 by researchers including Melissa Leach, James Fairhead, and Paul Richards with colleagues at Njala University in Sierra Leone, provided briefings to responders on burial practice, care arrangements, chieftaincy authority, and the local history that made state promises implausible.

Richards went further in his 2016 account, arguing that the epidemic ended in significant part because communities worked out for themselves how transmission operated and changed what they did. Villages instituted their own rules about visiting, nursing, and washing the dead, often before or beyond anything the response required. He called this a people's science, meaning ordinary epidemiological reasoning done by people with a direct interest in the answer. The claim is contested in its strong form, since case finding, treatment beds, and burial teams were scaling up at the same time, and separating those contributions is difficult. What is not contested is that the epidemic's end coincided with change inside communities as much as change imposed on them.

Blame has a geography

Farmer's first book, published in 1992, was about a Haitian village and about what the United States said concerning Haitians. In the early 1980s the Centers for Disease Control listed Haitian immigrants as a risk group for AIDS alongside behavioural categories, an inclusion by nationality that was removed in 1985 after epidemiological work showed the association reflected other exposures. The listing did lasting damage: Haitians in the United States lost jobs and housing, and in Haiti the tourist economy collapsed. Farmer called the pattern a geography of blame, in which accusation flows along lines of existing power, and each party locates the origin somewhere further down the chain.

The pattern repeated in 2020. Anti-Asian harassment rose sharply in several countries as the pandemic spread. Blame that runs downhill is the most reliable social feature of epidemics, more reliable than any particular control measure.

Refusal deserves the same treatment. In the Ebola outbreak in North Kivu in the Democratic Republic of the Congo, which ran from 2018 to 2020 in an area with decades of armed conflict, a survey published in 2019 found that a substantial minority of respondents in Beni and Butembo did not believe the outbreak was real, and that low trust in institutions predicted both that belief and lower willingness to accept vaccination. Read that as ignorance and you will design more leaflets. Read it as an assessment of an institution that people have had thirty years to evaluate, and you have a different and harder problem.

Remember: Rumour is a reasoning process about who can be trusted, running on the evidence people actually have. It responds to changed behaviour by institutions and rarely to information alone.

COVID, in the same frame

The largest epidemic of the anthropological era fits the pattern uncomfortably well. WHO declared a public health emergency of international concern on 30 January 2020 and used the word pandemic on 11 March. In May 2022 WHO published an estimate of 14.9 million excess deaths associated with the pandemic worldwide for 2020 and 2021, a figure far above the reported COVID death counts for the same period, with the gap largest where vital registration is weakest.

Three anthropological observations hold up.

First, exposure followed occupation and housing. The people who could not work from home, who commuted on crowded transport, who worked in meat processing or long-term care, and who lived in multigenerational households absorbed the risk. In the United States, age-adjusted mortality was substantially higher among Black, Hispanic, and American Indian and Alaska Native populations, and the mechanism was not genetic. It was who held which job and who lived how.

Second, control measures were negotiated, not simply issued. San Francisco passed a mask ordinance in 1918 and then produced an Anti-Mask League by January 1919, complete with public meetings and petitions. The 2020 arguments over masks, closures, and vaccine mandates were the same argument about the same question: how much can a state require of a healthy person on behalf of a stranger, and who decides.

Third, retrospection arrived on schedule. Every country has now told itself a story about its pandemic, and in most cases the story credits the tellers and recommends the reforms they already wanted.

So what?: If you know the four stages, you can predict roughly where an outbreak response will go wrong before it does, and the failures cluster at the same two places every time: the delay in admitting the thing exists, and the moment when control measures collide with obligations people cannot abandon.

Common misconceptions

• West African funeral practices caused the epidemic. Bat-to-human spillover started it and cross-border health system weakness let it spread; burial practice was one transmission route, and the successful fix preserved the funeral rather than banning it.
• Resistance to outbreak responses comes from ignorance. Refusal tracks institutional trust and local history, and in North Kivu it tracked an accurate reading of thirty years of state performance.
• Anthropologists were brought in to translate messages. Their contribution was to identify which obligations were non-negotiable and to redesign the intervention around them, which is analysis rather than translation.
• Reported death counts measure an epidemic's toll. WHO's excess mortality estimate for 2020 and 2021 was roughly three times the reported COVID deaths for that period.
• Blaming outsiders during epidemics is a modern failing. Accusation is one of the oldest and most consistent features of epidemics, and the 1980s listing of Haitians as an AIDS risk group is a documented case with measurable costs.

The short version

• Rosenberg's stages, progressive revelation, managing randomness, negotiating public response, and subsidence with retrospection, give you a reliable map of how an epidemic will unfold socially.
• The West African Ebola outbreak began in Guinea in December 2013, was recognized three months later, and produced about 28,600 cases and more than 11,300 deaths.
• Burial was the decisive transmission route, and the response worked once safe burial protocols were redesigned with religious leaders to preserve family presence, prayer, and a known grave.
• Anthropologists had been in Ebola responses since Gulu in 2000, and in 2014 the Ebola Response Anthropology Platform briefed responders on practice, authority, and history.
• Blame and refusal are reasoning about trust, from the listing of Haitians as an AIDS risk group in the early 1980s to survey evidence from North Kivu in 2019.
• COVID followed the same pattern, with exposure distributed by occupation and housing, control measures negotiated as they were in 1918, and WHO estimating 14.9 million excess deaths for 2020 and 2021.

Sources

1. Encyclopaedia Britannica. (n.d.). Ebola. britannica.com
2. World Health Organization. (n.d.). Coronavirus disease (COVID-19). who.int
3. National Center for Health Statistics. (n.d.). Mortality data. Centers for Disease Control and Prevention. cdc.gov
4. Rosenberg, C. E. (1989). What is an epidemic? AIDS in historical perspective. Daedalus, 118(2), 1-17.
5. Farmer, P. (1992). AIDS and accusation: Haiti and the geography of blame. University of California Press.
6. Hewlett, B. S., & Hewlett, B. L. (2008). Ebola, culture and politics: The anthropology of an emerging disease. Thomson Wadsworth.
7. Richards, P. (2016). Ebola: How a people's science helped end an epidemic. Zed Books.

Two hundred households and eleven kettles

Between 1954 and 1956 a public health worker in the Peruvian town of Los Molinos ran a campaign to persuade households to boil their drinking water. She visited homes, explained the reasoning, and returned repeatedly. Edward Wellin, who studied the campaign for Benjamin Paul's 1955 collection Health, Culture and Community, counted the result after two years: of roughly two hundred households, about eleven had adopted boiling.

The failure had nothing to do with stupidity and only partly to do with fuel costs, though fuel was expensive and boiling water on a small stove takes time a woman running a household does not have. The decisive obstacle was a classification. In that region, substances were sorted along a hot and cold axis that had little to do with temperature, and boiled water was classified as a hot substance appropriate for the sick. A healthy adult drinking boiled water was doing something that invited comment, like a healthy person carrying a hot water bottle around a modern office. Several of the women who did adopt boiling were people already marked as outsiders in the town, who had less social standing to lose.

Note what the campaign got right and what it never asked. The germ theory content was accurate, the health worker was diligent, and some residents accepted that invisible organisms caused illness and still did not boil. The question nobody asked was what the recommended act would mean about the person performing it.

Key idea: Interventions fail at the point where the recommended behaviour costs something the planners never counted: time, fuel, standing, or a claim about who you are.

The one disease that was actually eradicated

Set that against the greatest success in the history of public health. Smallpox killed an estimated three hundred million people in the twentieth century alone. WHO's Intensified Smallpox Eradication Programme began in 1967 with a plan for mass vaccination, and it was not working fast enough.

The change came from a supply shortage. In eastern Nigeria in late 1966, William Foege had too little vaccine to cover the population, so he used what he had to vaccinate the households and contacts around known cases, and watched transmission stop anyway. That approach, surveillance and containment, sometimes called ring vaccination, became the strategy: find every case, vaccinate the ring around it, and let the chain break. It works because you are not racing to immunize everyone; you are cutting the specific threads the virus is travelling along.

The last naturally occurring case was Ali Maow Maalin, a hospital cook in Merca, Somalia, in October 1977. The last death was Janet Parker, a medical photographer in Birmingham, England, in 1978, from a laboratory escape. On 8 May 1980 the World Health Assembly certified that smallpox had been eradicated.

The campaign is also worth studying for what it cost socially. Paul Greenough's research on the final South Asian phase documented episodes of intimidation and forced vaccination during containment, including entry into homes at night. The eradication was real and so was the coercion, and a course that reports only the first half is not teaching you the case.

Why smallpox and not the others

Compare four campaigns and the pattern becomes legible.

Campaign	What the biology allowed	What it asked of people	Where it ended up
Smallpox, 1967-1980	No animal reservoir, unmistakable rash, no symptomless carriers, heat-stable freeze-dried vaccine, lasting protection from one dose	Report cases; accept one vaccination during a containment episode	Certified eradicated in 1980
Global malaria eradication, 1955-1969	Mosquito vector, asymptomatic carriers, no vaccine at the time, insecticide resistance emerging	Accept repeated indoor spraying of every dwelling, indefinitely	Abandoned as a global goal in 1969 and replaced with control
Guinea worm, from 1986	No vaccine and no drug; the parasite can only be interrupted at the water source	Filter every drink; keep an infected limb out of the pond while the worm emerges	From an estimated 3.5 million cases in 1986 to a handful of human cases a year, now held up by infections in dogs
Polio, from 1988	Oral vaccine, but roughly one paralytic case per two hundred infections, so most transmission is invisible	Accept repeated door-to-door vaccination rounds, several times a year, for years	Wild types 2 and 3 eradicated, type 1 still transmitting in Afghanistan and Pakistan

Read down the third column. Smallpox asked for one act, once, in response to a visible event that people could see for themselves. Polio asks for repeated acts, indefinitely, against a disease that most families have never seen, delivered by teams who arrive again and again for one condition while nothing arrives for the child's diarrhoea. Guinea worm asks for a permanent change in how every household drinks. Difficulty of this kind is not measured in the laboratory.

Why this matters: The feasibility of an eradication campaign is a social property as much as a biological one, and the column that decides it is what the program asks of an ordinary household, how often, and for how long.

Two places where polio stalled, and why the rumours had referents

In mid-2003, political and religious leaders in Kano, Zamfara, and Kaduna states in northern Nigeria called for a suspension of oral polio vaccination, citing claims that the vaccine was contaminated with anti-fertility agents or with HIV. Vaccination stopped for roughly eleven months in Kano before resuming in July 2004. Cases rose in Nigeria and the virus was exported to countries that had been polio-free.

The vaccine claims were investigated and rejected. But the reason they were credible is documented and specific. In 1996, during a meningitis epidemic in Kano, Pfizer ran a trial of the antibiotic trovafloxacin on children in a treatment camp. The circumstances of consent became the subject of Nigerian government investigations and years of litigation, settled in 2009. A population that had watched an experiment run on its children during an emergency was not inventing the idea that outside medicine might have another agenda. It was generalizing from a case.

The Pakistani version is even more direct. In 2011 the Central Intelligence Agency organized a hepatitis B vaccination campaign in Abbottabad as cover for an attempt to obtain DNA from the compound where Osama bin Laden was living. After the operation was reported, attacks on polio vaccination teams followed; dozens of vaccinators and their police escorts have been killed since December 2012. In 2014 the White House stated that the agency would no longer use vaccination programs in intelligence operations. The damage was done to a campaign that had nothing to do with the operation, which is how trust works: it is held in institutions, not in projects.

Svea Closser's ethnography of the polio campaign in Pakistan adds the view from inside. Vaccinators were paid very little and worked under quotas; supervisors needed coverage numbers; and households that had been visited a dozen times for one disease, while the clinic remained unstaffed, began to refuse for reasons that had nothing to do with the vaccine.

What gets counted gets done, including the wrong thing

In 1978 delegates at Alma-Ata declared that primary health care, comprehensive and locally rooted, was the route to health for all by the year 2000. Within a year the declaration had a competitor. Julia Walsh and Kenneth Warren argued in the New England Journal of Medicine in 1979 that comprehensive primary care was unaffordable and proposed selective primary health care, a small package of high-impact interventions chosen by cost-effectiveness. UNICEF adopted a version of it in the early 1980s under the acronym GOBI: growth monitoring, oral rehydration, breastfeeding, and immunization.

This is the origin of the vertical and horizontal distinction in global health. A vertical program targets one disease with its own staff, budget, and reporting line, and can move fast. A horizontal program builds a health system that treats whatever comes through the door, and is slow, unglamorous, and difficult to attribute to any donor. Vertical programs are easier to fund because they are easier to count.

Vincanne Adams and colleagues traced what follows once counting becomes the organizing principle. Disability-adjusted life years, introduced in the World Bank's 1993 world development report and developed through the Global Burden of Disease studies, made interventions comparable across diseases, which was the point and was genuinely useful. It also meant that anything not expressible in that currency became invisible to funders: palliative care, mental health for a long period, the readiness of a district hospital to handle whatever arrives at three in the morning. Staff time gets pulled toward the activity that generates a reportable number, and the number improves while the clinic does not.

The Astana Declaration of 2018 reaffirmed the primary health care commitment of Alma-Ata, forty years later, which tells you how the argument has gone.

In short: Measurement systems are not neutral instruments for observing programs. They are incentives, and staff respond to them, so the question is never only what a program does but what its reporting requirements reward.

Five questions to ask before funding anything

1. What does this ask of a household per week, in hours and in money? Boiling water, filtering water, a daily observed pill, a clinic visit twenty kilometres away: price it in the currency the household actually has.
2. Who has to agree, and what does agreeing cost them socially? In Los Molinos the answer was standing. Elsewhere it is a husband, a mother-in-law, an employer, or a religious authority.
3. What does the program count, and what will people do to make that number look right? Assume the answer is the cheapest available action that produces the number, then ask whether that action is the one you wanted.
4. What is the local history of the institution delivering this? Not global history. What has this ministry, this agency, this donor done in this district, and who remembers it?
5. What happens the day the funding ends? If the answer is that the activity stops, you have bought an activity rather than a change.

Common misconceptions

• Failed health programs fail because people do not understand the science. In Los Molinos some residents accepted germ theory and still did not boil, because the act itself carried a meaning about the person doing it.
• Smallpox eradication proves any disease can be eradicated with enough money. Smallpox had no animal reservoir, no symptomless transmission, a visible rash, and a heat-stable vaccine, and none of those conditions holds for polio or malaria.
• Vaccine refusal is irrational. The Kano boycott followed a documented trial of an antibiotic on children during a meningitis emergency, and Pakistani hostility to vaccinators followed an actual intelligence operation conducted under vaccination cover.
• Vertical programs are simply more efficient. They are easier to count, which is not the same thing, and they draw staff and attention from services that treat whatever arrives.
• Eradication campaigns are gentle by nature. The final phase of smallpox containment in South Asia included documented coercion, and the campaign succeeded partly because of measures a health ministry today would struggle to defend.

What to carry forward

• The Los Molinos water-boiling campaign persuaded about eleven of two hundred households in two years, and the obstacle was a local classification that made boiled water a sick person's drink.
• Smallpox was eradicated by surveillance and containment rather than universal vaccination, certified in 1980, and its biology asked one act of a household rather than a permanent change.
• Malaria eradication was abandoned in 1969, guinea worm has fallen to a handful of human cases but is sustained in dogs, and wild poliovirus type 1 still circulates in two countries.
• Refusal in Kano and hostility in Pakistan each followed a documented local event, which is why treating rumour as an information deficit produces leaflets rather than trust.
• The vertical and horizontal argument runs from Alma-Ata in 1978 through selective primary health care in 1979 to Astana in 2018, and metrics such as disability-adjusted life years shape what programs do as much as they describe it.

Sources

1. Encyclopaedia Britannica. (n.d.). Smallpox. britannica.com
2. Global Polio Eradication Initiative. (n.d.). Polio today and the eradication effort. polioeradication.org
3. The Carter Center. (n.d.). Guinea worm eradication program. cartercenter.org
4. World Health Organization. (n.d.). Primary health care. who.int
5. Paul, B. D. (Ed.). (1955). Health, culture and community: Case studies of public reactions to health programs. Russell Sage Foundation.
6. Walsh, J. A., & Warren, K. S. (1979). Selective primary health care: An interim strategy for disease control in developing countries. New England Journal of Medicine, 301(18), 967-974.
7. Closser, S. (2010). Chasing polio in Pakistan: Why the world's largest public health initiative may fail. Vanderbilt University Press.
8. Adams, V. (Ed.). (2016). Metrics: What counts in global health. Duke University Press.

A wire story, 25 July 1972

On 25 July 1972 the Associated Press ran a story by Jean Heller reporting that the United States Public Health Service had spent forty years studying untreated syphilis in Black men in Macon County, Alabama. The study had begun in 1932 with six hundred men, of whom about four hundred had latent syphilis. They were told they were being treated for bad blood. They were given placebos, aspirin, and diagnostic spinal taps described to them as treatment. When penicillin became the standard cure in the late 1940s, they were not given it, and the researchers took steps to keep them from being treated elsewhere.

The study had not been secret. It was published in medical journals for decades. It ended not because a scientist objected internally, though Peter Buxtun had been objecting internally for years, but because a reporter published it and the public reaction was immediate. A panel convened; the study was terminated in November 1972; Congress passed the National Research Act in 1974; and in 1979 the commission that act created issued the Belmont Report. President Clinton apologized on behalf of the United States in May 1997, to five surviving participants.

Every institutional review board in the country is downstream of that wire story. So is a good deal of what happens when a medical anthropologist walks into a clinic.

The point: Research ethics rules are not abstractions handed down by philosophers. They are the scar tissue of specific abuses, and knowing which abuse produced which rule tells you what the rule is actually for.

Three principles and the machinery they built

The Nuremberg Code of 1947 came out of the trial of Nazi physicians and put voluntary consent first. The World Medical Association's Declaration of Helsinki, adopted in 1964 and revised many times since, set standards for physicians conducting research. The Belmont Report of 1979 gave American regulation its three principles, and they are worth holding in exactly these terms.

• Respect for persons. Treat people as capable of deciding for themselves, and protect those whose capacity is diminished. This is where informed consent comes from.
• Beneficence. Do not harm, and maximize possible benefits against risks. This is where risk-benefit assessment comes from.
• Justice. Distribute the burdens and benefits of research fairly. This is the principle Macon County violated most flagrantly: the risk fell on poor Black tenant farmers and the knowledge went elsewhere.

The regulatory machinery followed: the Common Rule, the network of institutional review boards, and a set of forms. That machinery was designed around a clinical trial, in which the intervention is defined in advance, the participants are enrolled at a moment, and consent is a signature on a document. Almost none of that describes what an ethnographer does.

Why the template fits ethnography badly

Consider what participant observation in a hospital actually involves and the mismatch becomes obvious.

The question changes while you work. A trial protocol specifies its primary outcome before enrolment. An ethnographer who already knew what she would find would not need to go. Review boards ask what you will study, and the honest answer is often that the first three months will tell you.

Consent is not an event. You will be present for months. People forget you are a researcher, because forgetting is what happens to a person who is always there. The practice that has developed is to consent repeatedly and out loud: reintroducing yourself, saying what you are writing down, offering people the chance to take something back afterward. Nothing in the form captures this, which is why the form is the floor rather than the ceiling.

The unit is a place. When you observe a ward round, you observe everyone on it: the patient, three relatives, a nurse who did not volunteer, and a student being corrected in front of others. Consent from all of them is often impossible, so the ethnographer trades away detail instead.

Anonymity is harder than it looks. Change every name and you still have a problem, because a hospital described as having one female cardiothoracic surgeon and a particular ward layout is identifiable to anyone who works there. This is deductive disclosure, and defending against it means altering details that do not carry the argument, or aggregating cases, and saying in the text that you have done so.

A signature can be the dangerous document. Among undocumented migrants, people who use illegal drugs, or anyone in a conflict zone, a signed paper linking a name to a study is the greatest risk the study creates. Review boards can and do waive documentation of consent for exactly this reason, and the revised Common Rule that took effect in 2018 also removed some activities, including oral history and journalism, from the definition of research requiring review.

Remember: The ethical work in ethnography happens continuously in the field, not once at a desk. A board can approve a project; it cannot decide what you say when a patient asks you a question at two in the morning.

The discipline's own rules

The American Anthropological Association's principles of professional responsibility, in the version adopted in 2012, place do no harm first, ahead of the pursuit of knowledge, and the ordering is deliberate. Other principles require openness about who you are and who funds you, obtaining consent and the necessary permissions, weighing obligations to collaborators against obligations to the wider public, making results accessible, protecting records, and maintaining ethical professional relationships.

The hardest consequence is one that anthropologists discuss more than they publish about: if the only way to write something true is to expose people who trusted you, the discipline's answer is that you do not write it. That is a genuine cost. Findings are lost, and the loss is not always small.

Three dilemmas you will actually meet

Being mistaken for staff. You are in a white-walled room holding a notebook, and a patient's daughter asks you what the consultant meant by the word they used. Practicing medicine is not available to you, and neither is pretending you heard nothing. The workable answer has three parts: say again who you are, help the family formulate the question, and get the clinician back. The related trap is well documented in trials, where Paul Appelbaum and colleagues named the therapeutic misconception in 1982: participants understand research procedures as care individually chosen for them, because that is what everything else in a hospital is.

Seeing harm. Sooner or later you will observe care you believe is substandard, or worse. Nancy Scheper-Hughes has argued the interventionist case most forcefully, calling for a militant anthropology in which the ethical claim of the person in front of you outranks the observational relationship. The counterargument is not indifference: it holds that an ethnographer is often not competent to judge a clinical decision from outside, that intervening ends the access that would let you document a pattern rather than an incident, and that a single reported incident may achieve less than a published account of a systemic failure. Both positions are held by serious people. The practical resolution is procedural: know the mandatory reporting law where you are working, agree an escalation route with the institution before fieldwork begins, and write down in advance what threshold will make you act, because the threshold you set in the moment will be the one that is most convenient.

Being asked for help you could give. You have a car; the clinic is twelve kilometres away; the participant has no fare. Henry Richardson and Leonard Belsky set out the problem of ancillary care obligations in 2004: what does a researcher owe a participant for needs the research itself did not create but did discover? Refusing everything is defensible on paper and monstrous in practice. Giving everything creates dependence, distorts what you are observing, and is unavailable to the next researcher. Most fieldworkers settle on a rule set in advance and applied consistently, and then break it occasionally and write about having done so.

What matters here: Decide your rules before you are in the room. Every one of these dilemmas is easier to resolve honestly in advance than under the pressure of a person asking you for something.

Two cases where the discipline got it wrong

In 1990 researchers from Arizona State University collected blood samples from members of the Havasupai Tribe, who live in the Grand Canyon, for a study of the tribe's high rate of type 2 diabetes. The samples were later used for research on schizophrenia, on inbreeding, and on population migration, none of which had been the basis of consent. The migration work also produced an account of the tribe's origins that contradicted their own. The tribe sued, and in 2010 the Arizona Board of Regents settled, paying 700,000 dollars to forty-one tribal members, returning the remaining samples, and providing other assistance. The case reshaped how genetic research with indigenous communities is negotiated, and the operative lesson is narrow and useful: consent is specific, and a sample given for one purpose is not a donation to science in general.

The second case shows the discipline overcorrecting. Patrick Tierney's 2000 book about research among the Yanomami in Venezuela and Brazil accused earlier researchers of grave misconduct, including causing a measles epidemic through a vaccination campaign. An American Anthropological Association task force reported in 2002; the most serious accusation was rejected by independent review, and in 2005 the association's membership voted to rescind the acceptance of the task force report. What did survive scrutiny was more mundane and more instructive: blood samples collected in the 1960s under consent arrangements that would not be accepted today, held in American institutions for decades, and repatriated only after sustained Yanomami requests, beginning in 2015. A community's objection to the storage of its members' blood does not require a scandal to be legitimate.

Six questions before you enter a clinical field site

1. Whose permission is genuinely required, and whose is merely convenient? A hospital administrator can grant access but cannot consent on a patient's behalf.
2. How will you re-consent, in what words, and how often?
3. What is the deductive disclosure risk, and which details will you change or aggregate in writing?
4. What will you do the first time you see harm? Write the threshold down before you go, along with the number you will call.
5. What will you provide when someone asks for help you could give, and what will you refuse? Set the rule in advance and apply it to everyone.
6. Who reads the manuscript before publication, and what happens if they object to something accurate?

Common misconceptions

• The Macon County study was secret. It was published in medical journals for four decades and ended after a wire story in July 1972, not after an internal objection was upheld.
• Approval from a review board makes fieldwork ethical. Approval is a floor. The decisions that matter are made in the room, months later, and no form anticipates them.
• Changing names protects participants. Deductive disclosure means an institution and its staff can often be identified from structural detail alone, so pseudonyms are only the beginning of the protection.
• Getting a signature is always the safer choice. For undocumented migrants and others, the signed document linking a name to a study is the principal risk, which is why waivers of documented consent exist.
• The primary obligation is to knowledge. The American Anthropological Association places do no harm ahead of the pursuit of knowledge, which sometimes means a true finding is not published.

Putting it together

• Research ethics regulation in the United States is downstream of the Macon County syphilis study, exposed in July 1972, terminated that November, and answered by the National Research Act of 1974 and the Belmont Report of 1979.
• Belmont's three principles, respect for persons, beneficence, and justice, generate consent, risk-benefit assessment, and fair distribution of research burdens respectively.
• The consent machinery was built for trials and fits ethnography badly, so ethnographers consent repeatedly and aloud, aggregate identifying detail, and sometimes avoid written signatures entirely.
• The recurring clinical dilemmas are role confusion, witnessed harm, and ancillary care, and each is best resolved by a rule set before entering the field.
• Havasupai established that consent is specific to a purpose, and the Yanomami controversy showed both the cost of an unsupported accusation and the legitimacy of a community's claim over samples taken from its members.

Sources

1. Office for Human Research Protections. (n.d.). The Belmont Report and human subjects regulations. United States Department of Health and Human Services. hhs.gov
2. American Anthropological Association. (2012). Principles of professional responsibility. americananthro.org
3. Centers for Disease Control and Prevention. (n.d.). The United States Public Health Service untreated syphilis study at Tuskegee. cdc.gov
4. World Medical Association. (n.d.). Declaration of Helsinki: Ethical principles for medical research involving human subjects. wma.net
5. Appelbaum, P. S., Roth, L. H., & Lidz, C. (1982). The therapeutic misconception: Informed consent in psychiatric research. International Journal of Law and Psychiatry, 5(3-4), 319-329.
6. Scheper-Hughes, N. (1995). The primacy of the ethical: Propositions for a militant anthropology. Current Anthropology, 36(3), 409-440.
7. Richardson, H. S., & Belsky, L. (2004). The ancillary-care responsibilities of medical researchers. Hastings Center Report, 34(1), 25-33.